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Summary 
 
INTRODUCTION: In patients with acute respiratory distress syndrome (ARDS) 
disruption of the epithelial barrier results in accumulation of edema fluid in the airspaces, 
impairing gas exchange and leading to elevated CO2 levels (hypercapnia). Moreover, lung-
protective mechanical ventilation in patients often results in further hypercapnia. The 
formation of new cell-cell contacts after ARDS is essential for the re-establishment of an 
intact and functional alveolar epithelium, capable of clearing lung edema and performing 
gas exchange. The Na,K-ATPase β-subunit is a cell-adhesion molecule with a key role in 
the formation and stability of cell junctions and therefore might be important in the repair 
of the alveolar epithelium. However, the effects of hypercapnia on the stability of the 
Na,K-ATPase β-subunit and on the re-organization of adherens junctions have not been 
studied before. In the present work we tested the hypothesis that hypercapnia inhibits cell-
cell contact formation by promoting the down-regulation of the Na,K-ATPase β-subunit. 
We aimed to elucidate the molecular mechanism underlying the (dis)regulation of adherens 
junction formation by hypercapnia. 
METHODS AND RESULTS: Exposing alveolar epithelial cells to elevated CO2 
at constant extracellular pH of 7.4 led to the ubiquitination of the Na,K-ATPase β-subunit 
at the plasma membrane which resulted in a significant reduction of the protein abundance 
at the cell surface, as determined by cell-surface biotinylation and confocal microscopy. 
Internalization of the Na,K-ATPase β-subunit was followed by proteasome-dependent 
degradation of the protein, as assessed by pulse-chase experiments with impermeable 
biotin. The simultaneous mutations of lysines 5 and 7 of the Na,K-ATPase β-subunit to 
arginine prevented hypercapnia-induced ubiquitination and endocytosis of the protein, 
demonstrating that ubiquitin chains covalently-attached to the Na,K-ATPase β-subunit 
during hypercapnia act as an endocytosis signal. Mutation of serine 11 of the Na,K-
ATPase β-subunit to alanine prevented hypercapnia-induced ubiquitination and 
degradation of the protein. In contrast, mutation of serine 11 to aspartate which mimics 
phosphorylation did not prevent hypercapnia-induced effects, suggesting that 
phosphorylation of the Na,K-ATPase β-subunit at serine 11 is a prerequisite for the 
ubiquitination of the protein. Coimmunoprecipitation and in vitro interaction studies 
showed that the serine/threonine kinase protein kinase C-ζ (PKC-ζ), known to be activated 
by hypercapnia, interacted with the Na,K-ATPase β-subunit and this interaction was 
dependent on the serine 11 of the Na,K-ATPase β-subunit. Moreover, PKC-ζ activity was 
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required for the hypercapnia-mediated effects, since the chemical inhibition or knock-
down of the kinase prevented the endocytosis of the Na,K-ATPase β-subunit under 
hypercapnic conditions. By the use of a protein-interaction microarray we identified the E3 
ligase TRAF2 as an interactive partner for Na,K-ATPase β-subunit. This interaction was 
further confirmed by coimmunoprecipitation and in vitro interaction studies. TRAF2 led to 
ubiquitination of the Na,K-ATPase β-subunit in vitro and in vivo. Moreover, knock-down 
of TRAF2 prevented the hypercapnia-induced endocytosis of the Na,K-ATPase β-subunit, 
demonstrating that TRAF2 is the E3 ligase that mediates the Na,K-ATPase β-subunit 
ubiquitination in hypercapnia. Most importantly, by cell aggregation assays we 
demonstrated that hypercapnia led to impaired cell junction formation, effect that was 
prevented by the simultaneous mutations of lysines 5 and 7 of the Na,K-ATPase β-subunit, 
demonstrating that hypercapnia-mediated down-regulation of the Na,K-ATPase β-subunit 
at the plasma membrane is the underlying mechanism by which hypercapnia inhibits cell-
cell adhesion. 
CONCLUSIONS: Here we report a novel mechanism by which hypercapnia 
affects the function of the alveolar epithelium. We provide evidence that hypercapnia 
(independently of pH) promotes ubiquitination of the Na,K-ATPase β-subunit at the 
plasma membrane leading to the endocytosis of the protein, which results in reduced 
ability of alveolar cells to form intercellular junctions. We demonstrate that ubiquitination 
depends on PKC-ζ activity and we identify TRAF2 as the E3 ligase that mediates the 
hypercapnia-induced ubiquitination of the Na,K-ATPase β-subunit. Thus, hypercapnia may 
impair restoration of the alveolo-capillary barrier in patients with ARDS upon hypercapnia 
by the down-regulation of the Na,K-ATPase β-subunit. 
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Zusammenfassung   
 
EINLEITUNG: Die Schädigung der epithelialen Schranke in Patienten mit akutem 
Lungenversagen (engl. acute respiratory distress syndrome, ARDS) führt zur Ausbildung 
alveolärer Ödeme und folglich zu erhöhten CO2-Leveln (Hyperkapnie). Zudem kann die 
lungenprotektive Beatmung mit geringen Tidalvolumen Hyperkapnie induzieren. Zur 
Auflösung von ARDS ist daher die Ausbildung neuer Zell-Zell-Kontakte für die 
Wiederherstellung eines intakten und funktionalen alveolären Epitheliums, das zur 
Resorption der Ödemflüssigkeit und Aufnahme des normalen Gasaustausches in der Lage 
ist, essenziell. Die β-Untereinheit der Na,K-ATPase ist ein Zelladhäsionsmolekül und 
spielt eine Schlüsselrolle in Ausbildung und Aufrechterhaltung von Zell-Zell-Kontakten 
und kann daher auch als wichtige Komponente für die Wiederherstellung der alveolo-
kapillaren Schranke von Interesse sein. Allerdings ist bisher nicht bekannt, inwieweit 
erhöhte CO2-Level einen Einfluss auf die Stabilität der Na,K-ATPase β-Untereinheit und 
die Reorganisation von Adherens Junctions haben. In der vorliegenden Arbeit sollte daher 
untersucht werden, ob und über welche molekularen Mechanismen Hyperkapnie die 
Regulation von Adherens Junctions reguliert und ob die Ausbildung von Zell-Zell-
Kontakten durch eine Herunterregulation der Na,K-ATPase β-Untereinheit inhibiert wird.  
METHODEN AND ERGEBNISSE: Oberflächen-Biotinylierung und konfokale 
Mikroskopie humane alveolarer epithelialer A549 Zellen zeigen, dass die Behandlung mit 
hohen CO2-Konzentration 120mmHg) zu einer schnellen Ubiquitinierung der an der 
Plasmamembran befindlichen Na,K-ATPase β-Untereinheit, und in Folge dessen zu einer 
signifikanten Reduktion der Häufigkeit dieser Untereinheit an der Plasmamembran führt. 
Pulse-Chase Experimente mit nicht-zellpermeablem Biotin demonstrieren, dass nach der 
Hyperkapnie-induzierten Internalisierung der Na,K-ATPase β-Untereinheit eine 
proteosomale Degradation des Proteins folgt. Die gleichzeitige Mutation von Lysin 5 und 7 
der Na,K-ATPase β-Untereinheit verhindert die Hyperkapnie-induzierte Ubiquitinierung 
und Endozytose des Proteins. Die Mutation von Serin 11 der Na,K-ATPase β-Untereinheit 
zu Alanin verhindert die Hyperkapnie-induzierte Ubiquitinierung und Degradierung, 
wohingegen die Mutation von Serin 11 zu Aspartat, was eine Phosphorylierung imitiert, 
die Hyperkapnie-induzierten Effekte nicht verhindert. Koimmunopräzipitation und in vitro 
Experimente zur Interaktion der Protein belegen, dass die PKC-ζ Serin/Threonin-Kinase, 
die bekannterweise während der Hyperkapnie aktiviert wird, mit der Na,K-ATPase β-
Untereinheit interagiert und diese Interaktion abhängig ist von Serin 11 der Na,K-ATPase 
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β-Untereinheit. Weiterhin verhindert die chemische Inhibition oder der knock-down von 
PKC-ζ die Hyperkapnie-induzierte Endozytose der Na,K-ATPase β-Untereinheit. In einem 
Protein-Microarray zur Identifikation von Bindungspartnern der Na,K-ATPase β-
Untereinheit wurde die E3 Ligase TRAF2 gefunden, die auch in 
Koimmunopräzipitationsstudien und in in vitro Interaktionsstudien die Na,K-ATPase β-
Untereinheit bindet. TRAF2 induziert die Ubiquitinierung der Na,K-ATPase β-
Untereinheit in vitro und in vivo. Außerdem verhindert der Knock-down von TRAF2 die 
Hyperkapnie-induzierte Endocytose der Na,K-ATPase β-Untereinheit. Durch 
Zellaggregationsassays konnten wir zeigen, dass Hyperkapnie zu gestörten Zell-Zell-
Adhäsionen führt und dieser Effekt durch Mutation der Lysine 5 und 7 der Na,K-ATPase 
β-Untereinheit verhindert werden konnte. 
ERGEBNIS: In dieser Studie zeigen wir einen neuen Mechanismus auf, über den 
Hyperkapnie Einfluss auf die Funktion des alveolären Epitheliums nimmt. Wir belegen, 
dass Hyperkapnie unabhängig vom pH die Ubiquitinierung und infolgedessen die 
Endozytose der Na,K-ATPase β-Untereinheit induziert, wodurch die Fähigkeit alveolarer 
Zellen zur Ausbildung von Zell-Zell-Kontakten reduziert wird. Weiterhin demonstrieren 
wir, dass die Ubiquitinierung der Na,K-ATPase β-Untereinheit von der Aktivität von PKC-
ζ abhängt, und dass TRAF2 die E3 Ligase ist, die die Hyperkapnie-induzierte 
Ubiquitinierung vermittelt. Demzufolge könnte Hyperkapnie die Wiederherstellung der 
alveolo-kapillaren Schranke in Patienten mit ARDS durch eine Herunterregulation der 
Na,K-ATPase β-Untereinheit behindern. 
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1. Introduction 
 
1.1. Acute respiratory distress syndrome 
 
The acute respiratory distress syndrome (ARDS) is the cause of 40% mortality in 
approximately 200000 patients per year in the United States [1]. ARDS is a syndrome of 
acute respiratory failure in which patients present progressive arterial hypoxemia, dyspnea, 
and a marked increase in the work of breathing. Arterial hypoxemia is caused by 
accumulation of edema fluid in the distal air spaces in the lung, which impairs blood gas 
exchange. ARDS occurs within hours to days of a predisposing event and most patients 
require endotracheal intubation and positive pressure ventilation [2]. In 1994, the 
American-European Consensus Conference proposed a definition, widely employed for 
more than 15 years as a diagnostic tool, in which ARDS is defined as a syndrome 
characterized by acute onset of bilateral pulmonary infiltrates with arterial hypoxemia, 
judged by the ratio of arterial partial pressure of oxygen to fraction of inspired oxygen 
(PaO2/FiO2 ratio), in the absence of left atrial hypertension. If PaO2/FiO2 ratio is less than 
300 mmHg, patients are considered to present with acute lung injury (ALI) and if 
PaO2/FiO2 ratio is less than 200 mmHg, patients are considered to present with ARDS [3]. 
In 2012, with the aim to simplify diagnosis and improve mortality prediction, a revised 
version of ARDS definition, called Berlin Definition, was adopted. By this definition, 
ARDS is now classified into mild, moderate and severe according to PaO2/FiO2 ratios of 
<300, <200 or <100 mmHg respectively in patients with a PEEP of 5 cm H2O or grater [4].  
Different clinical disorders may lead to the development of ARDS. The most 
prevalent cause of ARDS is primary pneumonia, which can be bacterial, viral, or fungal [5, 
6]. The second most common cause of lung injury is severe sepsis. Other causes include 
gastric contents aspiration and major trauma [6]. 
Pathogenic changes observed during the course of ARDS can be classified into 
three phases: (i) an early exudative phase evidenced by the presence of interstitial and 
alveolar edema with accumulation of neutrophils, macrophages and blood cells in the 
alveolar space and endothelial and epithelial injury; (ii) a proliferative phase with 
pneumocyte hyperplasia and proliferation of myofibroblasts; and (iii) a fibrotic phase with 
collagen deposition and fibroproliferation. In some patients with persistent inflammation, 
fibroproliferation continues leading to lung fibrosis [5, 7, 8]. 
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ARDS is primarily driven by an increase in the permeability to protein-rich fluid 
across the endothelial and epithelial barriers of the lung [9].  Different events may trigger 
endothelial injury, although neutrophil-mediated lung injury is probably the best 
documented pathway. Neutrophils may accumulate in the lung microvasculature, become 
activated leading to degranulation and release of several mediators, including proteases, 
reactive oxygen species (ROS), proinflammatory cytokines and procoagulant molecules 
causing the increase in vascular permeability and the loss the normal endothelial barrier 
function [2, 10-12] (Figure 1, Figure 2). Increased pulmonary microvascular permeability 
can result in the accumulation of protein-rich edema [13, 14]. However, endothelial injury 
alone is insufficient to cause ARDS. Under normal conditions, the epithelial barrier is 
much tighter than the endothelial barrier and prevents cells and plasma from invading the 
air spaces. An injury to the alveolar epithelium is necessary for the accumulation of 
protein-rich fluid in the alveolar air spaces and the development of ARDS [15, 16]. It has 
been shown in animal models that endothelial injury by intravenous administration of 
endotoxin, in the absence of injury to the lung epithelium, was not sufficient to cause the 
development of alveolar edema. Only when the epithelial barrier function was also 
impaired by instillation of live bacteria, edema formation was evident [16, 17]. In line with 
these data, lung biopsies from patients dying from ARDS presented both endothelial and 
epithelial injury in the lungs [5].  
The mechanisms responsible for epithelial injury during ARDS have not been fully 
elucidated. Experimental studies suggest that neutrophils and their products may initiate 
the damage to the alveolar epithelial barrier [2, 12, 17, 18]. Under pathologic conditions, 
large number of neutrophils may become activated and release toxic mediators such as 
proteases and ROS that may induce the disintegration of cell junctions and apoptosis and 
necrosis of alveolar epithelial cells [19] (Figure 1, Figure 2). 
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Figure 1: Schematic representation of inflammatory, non-inflammatory and mechanical stimuli and injures 
in the pathogenesis of ARDS [12].  
 
        
 
Figure 2: Schematic representation of impaired structures and functions of the alveolo-capillary barrier in 
ARDS [12]. 
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1.2. Structural features of the alveolar epithelium 
 
The alveolo-capillary barrier consists of an epithelial and endothelial monolayer, separated 
by a diminutive interstitial space. The close apposition between the alveolar epithelium and 
the vascular endothelium facilitates efficient gas exchange [20-22]. The alveolar 
epithelium contains equal numbers of thin, squamous alveolar type I (ATI) and cuboidal 
type II (ATII) cells, with the former accounting for approximately 95% of the surface area 
[23]. Both cell types contain well-organized adherens and tight junctions, and are 
polarized, displaying an asymmetric distribution of ion transporters, including the apical 
epithelial sodium channel (ENaC) and the basolaterally located Na,K-ATPase [24-26]. 
Thus, the intact alveolar epithelium regulates very tightly the permeability to proteins and 
solutes [24].  
 
1.3. Clinical relevance of the repair of the alveolar epithelial injury  
 
The alveolar epithelium, under physiological conditions, is much less permeable than the 
endothelium, and forms the primary barrier for solutes and electrolytes in the lung [15, 16, 
27, 28]. The loss of integrity of the epithelial barrier, a hallmark in ARDS, leads to the 
accumulation of edema fluid in the alveolar air spaces [5]. Injured epithelial cells lose the 
capacity to remove fluid from the alveolar air spaces and produce less surfactant, causing 
further damage to the epithelium [6, 15, 16, 29-32]. The magnitude of the epithelial injury 
strongly affects the clinical course of patients with ARDS. Delayed or impaired epithelial 
resealing and alveolar fluid clearance are associated with worse prognosis [9, 15, 16, 29, 
33, 34]. Severe injury to the alveolar epithelium, followed by inadequate repair, may lead 
to lung fibrosis [30]. 
 
1.4. Alveolar edema fluid clearance 
 
Manifestation of alveolar edema causes severe impairment of gas exchange leading to local 
hypoxia and systemic hypoxemia the former of which causes further disruption of the 
alveolar epithelial barrier and fluid balance [35]. A critical step toward ARDS resolution 
involves the removal of the alveolar edema fluid to the lung interstitium, where clearance 
can occur through lung lymphatic vessels and pulmonary microcirculation [2]. The primary 
force driving fluid reabsorption from the alveolar space into the interstitium is the vectorial 
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transport of Na+. Na+ is taken up on the apical surface of the alveolar epithelium by 
amiloride-sensitive and -insensitive Na+ channels and is subsequently “pumped” out of the 
cell by the Na,K-ATPase on the basolateral side [36, 37]. This process generates an 
osmotic gradient, which drives passive movement of water from the apical side of the 
epithelium (the alveolar space) to the basolateral side (the interstitium) paracellularly [12, 
37] (Figure 3).  
 
                    
 
Figure 3: Key elements in ARDS resolution [12]. 
 
1.5. Alveolar epithelial barrier resealing 
 
Only an intact alveolar epithelium can reabsorb fluid from the alveolar space and prevent 
further edema formation.. Therefore, a key factor in patients´ recovery from ARDS is the 
reconstitution of a normal alveolar structure. This involves spreading and migration of 
neighboring alveolar epithelial cells to cover denuded areas, migration and proliferation of 
progenitor cells to restore cell numbers, cell differentiation to restore function and cell 
junction organization to recover epithelium tightness and continuity [12, 15, 16, 38]. The 
major type of intercellular junctions responsible for re-establishing a tight epithelium are 
the tight junctions, adherens junctions and desmosomes [39, 40] (Figure 3).  
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1.6. Adherens junctions 
 
Adherens junctions are a form of cell-cell adhesion structure found in several cell types 
[41]. Epithelial cadherin (E-cadherin), a member of the cadherin superfamily, is a 
transmembrane protein that mediates Ca+-dependent homophilic cell-cell adhesion [42-44]. 
While the extracellular domain of E-cadherin establishes the interaction between adjacent 
cells, its cytoplasmic domain binds to intracellular adhesion molecules which link cell-cell 
adhesion to the actin cytoskeleton producing mature junctions [45-49]. Adherens junctions 
provide strong physical anchorage and participate in the generation of intracellular 
signaling [50].  These adherens junctions play a pivotal role in regulating the integrity and 
tightness of the epithelium and are involved in the formation of other cell-cell junctions 
[51, 52].  
 
1.7. Tight junctions 
 
The low paracellular permeability of the healthy pulmonary epithelium is due to the 
presence of tight junctions (TJ), belt-like interconnected junctional strands of proteins, 
connecting alveolar cells and separating the apical and basolateral surfaces of the 
epithelium [26, 53-55]. Tight junction proteins play a major role in regulating the lung 
barrier [24]. An emerging concept is that tight junction composition, as opposed to number 
of tight junction strands, determines the barrier properties [56]. ATI and ATII cells express 
occludin [57, 58], zonula occludens (ZO)-1 [55] and several members of the claudin family 
[59]. Claudins are a family of transmembrane proteins that are crucial structural and 
functional components of tight junctions, being claudin 3, 4 and 18 the most predominantly 
expressed in the alveolus [56]. Claudin 4 levels are positively correlated with an intact 
alveolar barrier function [60, 61] and it is up-regulated in response to ARDS [61]. Other 
stimuli such as oxidative stress, alcohol and NO2 exposition, can also lead to changes in the 
composition, expression and localization of tight junctions, which in turn affect the 
integrity of the alveolar epithelial barrier [62-64].  
 
1.8. The Na,K-ATPase  
 
The Na,K-ATPase, a member of the P-type ATPase superfamily, is expressed in all animal 
tissues, establishing concentration gradients for Na+ and K+ within the cell by pumping 
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three Na+ out of the cell and two K+ into the cell per ATP molecule consumed [65, 66]. 
The Na,K-ATPase heterodimer, composed of a catalytic α- and a regulatory β-subunit, is 
assembled in the endoplasmic reticulum (ER) and delivered to the plasma membrane of 
epithelial cells (Figure 4) [67-69]. The α-subunit is a 112 kDa polytopic membrane protein 
with ten transmembrane segments. It contains the catalytic activity of the enzyme and the 
binding sites for Na+, K+ and ATP [67, 70, 71]. The β-subunit is a single membrane 
spanning polypeptide with a small cytoplasmic domain and a large extracellular portion, 
containing three disulphide bridges and three N-glycosylation sites. Depending on the 
degree of glycosylation, which differs within species and tissues, the mature β-subunit has 
a molecular weight between 40-60 kDa [72, 73]. The Na,K-ATPase β-subunit has been 
shown to be critical for translation, correct folding and membrane insertion of the 
α-subunit of the Na+ pump [73]. To date, four α- and β-subunit isoforms have been 
identified in mammals, which are expressed in a tissue specific manner [74-76]. A third 
protein, termed the γ-subunit, can provide further tissue-specific regulation [77]. In the 
lung, the Na,K-ATPase localizes at the basolateral surface of ATI and ATII cells. Two 
isoforms of the Na,K-ATPase α-subunit (α1 and α2) and β-subunit are expressed in the 
alveolar epithelial cells, with the α1-subunit being expressed in both cell types, while the 
α2-subunit appears to be restricted to ATI cells [78-80]. 
The majority of the studies have been focused on the transport function of the 
Na,K-ATPase demonstrating its critical role in keeping alveoli free of edema [81]. 
However, growing evidence has demonstrated that the Na,K-ATPase is a multifunctional 
protein involved in the formation and maintenance of intercellular junctions, cell polarity, 
cell motility, cell signaling, actin dynamics and cancer [82, 83]. Thus, Na,K-ATPase could 
have physiological functions in the alveolar epithelium beyond ion transport. 
 
                      
 
Figure 4: High-resolution structure of the Na,K-ATPase (2ZXE) [84, 85].  
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1.9. The Na,K-ATPase β-subunit as a cell adhesion molecule 
 
The Na,K-ATPase is distributed in a highly polarized manner within epithelial cells. At the 
beginning of the formation of the epithelial monolayer, the major fraction of the Na,K-
ATPase is present at the basal membrane. During the formation of cell-cell contacts the 
Na,K-ATPase starts to accumulate at the lateral border of adjacent cells [86]. Studies 
conducted in CHO fibroblast cell lines provided evidence that β-subunit expression in 
these cells induced the polarized expression of the Na,K-ATPase and conferred CHO cells 
adhesive properties [87]. On the other hand, inhibition of the Na,K-ATPase activity by 
ouabain disrupted Na,K-ATPase polarized expression and impaired cell-cell adhesion [51, 
88, 89]. These results, together with the observation that β-subunit has a typical structure 
of an adhesion molecule [90, 91] are in line with a possible link between Na,K-ATPase 
and cell adhesion [87]. Studies conducted to examine the possibility that β-subunit is 
directly involved in cell-cell adhesion have consistently shown that the Na,K-ATPase β-
subunit directly participates in the formation intercellular adhesion [85, 92, 93]. It has been 
reported that the Na,K-ATPase colocalizes with adherens junctions in all stages of the 
monolayer formation starting from the initiation of cell-cell contact [86] (Figure 5). In 
fact, the Na,K-ATPase β-subunit has been shown to act as a cell adhesion molecule in the 
adherens junctions. The cytoplasmic domain of the Na,K-ATPase is linked to E-cadherin 
via ankyrin/spectrin cytoskeleton while the extracellular domain of β-subunit interacts with 
the β-subunit of adjacent cells [92, 93]. The strength of β-β interactions has been proven to 
be dependent on its N-glycans and its amino acid sequence [85, 86]. The impairment of β-β 
binding by alterations in β-subunit N-glycans or amino acid sequence, or by the use of β-
subunit blocking antibodies, caused instability of junctional complexes and increased 
paracellular permeability [85, 94-96]. These observations provide solid evidence that 
interactions between the Na,K-ATPase β-subunits of neighboring cells maintain the 
integrity of intercellular junctions. Taken together, these findings strongly support a major 
role of the Na,K-ATPase in the barrier function, separate from its role in the vectorial 
sodium transport.  
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Figure 5: Immunostaining of MDCK cells shows that YFP-tagged Na,K-ATPase β-subunit colocalizes with 
E-cadherin and β-catenin in the sites of cell contacts [86]. 
 
1.10. Role of the Na,K-ATPase β-subunit in the organization and maintenance of 
tight junctions  
 
The tightness of the healthy alveolar epithelium is due to the presence of tight junctions. It 
has been well-documented that E-cadherin and the β-subunit of the Na,K-ATPase play an 
essential role in the formation of tight junctions and establishment of epithelial polarity 
[46, 97-100]. Some of these studies were performed in Maloney sarcoma virus (MSV)-
transformed Madin-Darby canine kidney (MDCK) cells, which express low levels of E-
cadherin and Na,K-ATPase β-subunit and display a non-polarized phenotype. Experiments 
in which E-cadherin and  Na,K-ATPase β-subunit were expressed, demonstrated that the 
simultaneous expression of both proteins is required for MSV-transformed MDCK to form 
functional tight junctions and display a polarized phenotype [97].  
Additional evidence on the role of the Na,K-ATPase in tight junction formation has 
been provided by studies in mice embryos. These studies showed that Na,K-ATPase β-
subunit is required for blastocyst formation and that the lack of β-subunit expression led to 
aberrant distribution of the Na,K-ATPase α-subunit and tight junction proteins during pre-
implantation development [101]. 
The molecular mechanisms involved in the formation of tight junctions might differ 
from the mechanisms required to maintain tight junctions. In fact, although E-cadherin 
function is critical for the formation of tight junctions, its function appears to be 
dispensable once the cells have established the tight junctions. The Na, K-ATPase, on the 
other hand, has proven to be involved in both the establishment as well as the maintenance 
of functional tight junctions and epithelial polarity [97, 102]. Therefore, it is reasonable to 
propose that events leading to changes in Na,K-ATPase β-subunit expression, 
glycosylation pattern, distribution within the cell or stability may play a role in the 
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disruption of the alveolar epithelium and/or may cause delayed or impaired repair of the 
epithelial monolayer after injury. 
 
1.11. Regulation of the Na,K-ATPase 
 
In most polarized epithelial cells, the α- and β-subunit are expressed at an equimolar ratio, 
assembled as heterodimers, and delivered to the basolateral membrane where they 
contribute to active Na+ transport and maintain epithelial integrity [65]. The abundance of 
Na+ pump subunits and ATPase activity are tightly regulated by various stimuli. The pump 
is regulated by concentrations of its substrates as well as by changes in the molecular 
components of the surrounding environment (ions and non-ionic molecules). The Na,K-
ATPase is modulated by membrane-associated components such as cytoskeletal elements 
and regulatory FXYD proteins, such as γ-subunit. The pump is also affected by variations 
in oxygen, carbon dioxide and nitrogen availability. As an important molecule in charge of 
various biological events, the Na,K-ATPase is regulated by a number of circulating 
endogenous inhibitors and hormones, such as aldosterone, thyroid hormone, 
glucocorticoid, catecholamines, insulin, carbachol, estrogen and androgen [34, 103-107]. 
All these stimuli can exert either short term or long term regulation of the Na, K-ATPase. 
Long term regulation of Na,K-ATPase usually involves changes in RNA and protein 
synthesis or degradation of the Na,K-ATPase isoforms [104, 107-111]. Short term 
modulation of the Na,K-ATPase function may be mediated by changes in the cellular 
distribution of pump units by reversible post-translational mechanisms such as 
phosphorylation or ubiquitination, or by changes in the intracellular Na+ concentration 
which in turn modifies the pump kinetics [108, 111].  
Functionality of the Na,K-ATPase is fundamental for edema clearance during 
ARDS and not only experimental models of acute lung injury (ALI), but also patients with 
ARDS, are characterized by an impairment of the Na,K-ATPase function leading to a 
decreased ability of the lungs to clear edema and worse outcomes [33, 34].  
 
1.12. Hypercapnia 
 
In mammals, CO2 produced during aerobic cellular respiration is disposed by the lung. In 
patients with ARDS, the alveolar epithelium, the site of CO2 elimination, is exposed to 
elevated CO2 levels (hypercapnia), as a consequence of poor alveolar gas exchange. 
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Moreover, these patients often require mechanical ventilation with low tidal volumes 
which may result in a further increase in blood and tissue CO2 levels [112, 113]. 
Whether hypercapnia brings any benefit or harm to patients remains controversial. 
Some clinicians argue that hypercapnia and its associated acidosis may enhance patients´ 
outcomes, particularly by reducing inflammation during the course of ARDS [114-116]. 
However, the fact that buffering hypercapnic acidosis worsen experimental ARDS [117] 
suggests that some of these effects might be due to acidosis rather than hypercapnia per se 
[112]. Other clinicians argue that hypercapnia might be detrimental in patients and often, 
various techniques including extracorporeal carbon dioxide elimination are employed to 
treat hypercapnia and acidosis [112, 118]. The latter theory is supported by preliminary 
observations of a prospective cohort of 3400 patients receiving mechanical ventilation for 
at least 48 hours. This study has shown that patients who developed hypercapnia in the first 
48 hours had a higher incidence of new ARDS and required mechanical ventilation for 
longer periods [117]. High CO2 levels have also been associated with increased mortality 
in hospitalized patients with community-acquired pneumonia [119] and have been found to 
be a marker of poor prognosis in COPD [120, 121] and a risk factor in patients with cystic 
fibrosis waiting for lung transplantation [122].  
The notion of a sensor for CO2 has been proposed in plants and insects [123, 124]. 
In Drosophila, a CO2 sensitive receptor has been described in the olfactory neurons [123]. 
Recently, it has been reported that mice also can detect CO2 through the olfactory system 
involving carbonic anhydrase [125]. The effects of hypercapnia on excitable cells are well 
characterized and include depolarization of glomus cells, which trigger an increase in 
alveolar ventilation to maintain normal CO2 levels in the body [126]. In contrast, the 
effects of CO2 on non-excitable mammalian cells are incompletely  understood.  
Our group has conducted studies to evaluate the hypothesis that elevated CO2 levels 
have important deleterious effects on the alveolar epithelium, the site of CO2 elimination in 
mammals. Results from these studies have shown that non-excitable alveolar epithelial 
cells sense and respond to elevated levels of CO2, independently of extracellular and 
intracellular pH, by inhibiting Na,K-ATPase function. The decrease in Na+ pump function 
results in impaired alveolar fluid reabsorption in rats exposed to hypercapnia [127]. Over 
the recent years, our group has contributed to the better understanding of the CO2 signaling 
pathway. High CO2 levels lead to the Ca
+-dependent activation of Ca+/calmodulin-
dependent kinase kinase-β. This kinase causes the activation of a well-recognized 
metabolic sensor, the AMP-activated protein kinase (AMPK), which promotes cell 
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adaptation to stress [128]. AMPK leads to activation of protein kinase C-ζ (PKC-ζ), which 
phosphorylates the Na,K-ATPase α-subunit, causing it to endocytose from the plasma 
membrane into intracellular pools, thus altering its function [127, 128]. These results have 
been also reconfirmed in vivo in animals exposed to elevated CO2 levels for up to seven 
days [128]. 
These findings clearly demonstrate a deleterious effect of hypercapnia on Na,K-
ATPase-mediated edema clearance. However, it remains unknown whether hypercapnia 
also affects Na,K-ATPase β-subunit stability. Once at the plasma membrane Na,K-ATPase 
subunits can be independently and differently regulated and Na,K-ATPase β-subunit 
emerges as a critical target of study, considering its key role in the formation and 
maintenance of tight and adherens junctions and therefore potential impact on the epithelial 
barrier integrity and repair after ARDS. 
 
1.13. Ubiquitination  
 
The canonical role of ubiquitination is to mediate the degradation of proteins that carry 
ubiquitin on specific lysine residues. However, increasing evidence shows that protein 
modification by ubiquitin has diverse functions and is involved in a broad variety of 
cellular processes. It has been well-documented that the attachment of ubiquitin can act as 
an internalization signal that sends the modified substrate to the endocytic/sorting 
compartments [129, 130]. The Na,K-ATPase α-subunit is one example of the several 
membrane proteins whose trafficking is regulated by the ubiquitin system [131] 
Ubiquitin is a 76 amino acid peptide of 8.5 kDa. It is found in almost all tissues of 
all eukaryotic organisms and it is highly conserved among species, sharing 96% homology 
yeast and humans. Ubiquitin has a long half-life and is recyclable (Figure 6) [132-135]. 
 
                            
Figure 6: Ubiquitin structure. Key amino acid residues present in ubiquitin molecule are indicated [135]. 
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Ubiquitination is an enzymatic, post-translational modification process in which a 
ubiquitin peptide is covalently attached to a protein substrate. The process is very complex 
involving several enzymes and accessory proteins. The reaction occurs via sequential 
action of three enzymes: a ubiquitin-activating enzyme E1, a ubiquitin-conjugating enzyme 
E2 and a ubiquitin ligase E3 (Figure 7). The first step involves ATP-dependent ubiquitin 
activation by the formation of a high-energy thioester linkage between the carboxyl group 
of ubiquitin´s glycine 76 and E1´s cysteine in the active-site. A second step involves the 
transfer of the high-energy thioester bond from the E1 to the active-site cysteine of one of 
~40 E2s (in mammals). Finally, a third step consists of the transfer of the ubiquitin peptide 
from the E2 to the ε-amino group of a substrate´s lysine. This final step is mediated by one 
of the ~600 E3s (in mammals) [132, 136, 137].  
 
        
 
Figure 7: Schematic representation of the ubiquitination reaction. By the ATP-dependent sequential action of 
three enzymes: a ubiquitin-activating enzyme E1, a ubiquitin-conjugating enzyme E2 and a ubiquitin ligase 
E3, the ubiquitin molecule is covalently attached to a substrate which is often phosphorylated (P-substrate). 
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1.14. RING E3 ligases 
 
The specificity and diversity of ubiquitination is a consequence of the hierarchical order of 
the ubiquitin enzymatic cascade. Although one or two E1s activate the ubiquitin 
conjugation machinery, a large number of E2 conjugating enzymes and E3 ligases have 
been identified [138] (Figure 8). 
  
 
 
Figure 8: Schematic representation of the hierarchical structure of ubiquitin-conjugating machinery [138]. 
E1 can activate several E2s which act in turn on several E3s. E3s can be substrate-specific or can recognize 
some substrates via similar, but not identical, motifs. Some substrates may be recognized by different E3s via 
diverse motifs.  
 
Ubiquitination has to occur with exquisite spatial, temporal and substrate 
specificity. E3 ligases determine the specificity of the ubiquitination reaction by 
specifically recognizing their substrates, by selecting the lysines to be modified by 
ubiquitin, and by catalyzing the formation of the same product (same size and chain 
topology) each time they act on their substrate [136]. Two primary classes of E3s have 
been described. The first is characterized by the presence of a homologous to E6-AP 
carboxyl terminus (HECT) domain [139]; the second by a really interesting new gene 
(RING)-finger domain [140, 141]. HECT E3 ligases participate in the catalytic reaction by 
forming a thioester bond between ubiquitin and the E3´s active-site cysteine, followed by 
the transfer of ubiquitin to the substrate. RING E3 ligases, on the other hand, mediate the 
direct transfer of ubiquitin from E2 to the substrate [130, 136].  
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RING-type E3 ligases are the most abundant in nature. The mammalian genome 
encodes more than 600 potential RING finger E3s [142]. RING E3s do not possess 
intrinsic catalytic activity. Its RING finger domain, containing series of spaced cysteine 
and histidine residues that coordinate Zn2+, facilitates E2-dependent ubiquitination [143]. 
Based on the interpretation of E2-E3 complexes crystal structures, it is believed that RING 
E3 ligases contribute to catalysis by acting as scaffold proteins that bring together the 
active site of E2 and the acceptor lysine residue of the substrate. They may make an 
additional contribution by inducing allosteric activation of E2s [144]. RING E3 ligases can 
function as monomer, dimers or multiprotein complexes [136].  
Substrate recognition by the appropriate E3 ligase can be influenced by the 
presence of accessory proteins, by subcellular compartmentalization of E3s and substrate, 
and by post-translational modifications, such as phosphorylation or neddylation of the 
substrate or the E3 ligase [136, 145-149]. The best studied regulatory mechanism of the 
ubiquitination process is phosphorylation. Phosphorylation of E3 ligases can regulate 
substrate ubiquitination either positively or negatively. RING E3 ligases are very often 
tightly regulated through phosphorylation which can promote or inhibit its binding to 
substrate proteins or E2 enzymes [149]. Substrate phosphorylation can also regulate E3 
ligase-mediated substrate ubiquitination [149-151]. Phosphorylation itself can create a 
recognition signal or “phosphodegron” for binding of an E3 ligase. Phosphorylation can 
induce conformational changes in the substrate and result in exposure of degrons. 
Phosphorylation may also regulate substrate compartmentalization and therefore control 
the access of an E3 ligase to its target [149, 152]. 
It has been observed that the attachment of ubiquitin molecules to the substrate´s 
lysines take place on unstructured regions that are located near the degron elements bound 
by E3s. In most cases, there is no consensus sequence for ubiquitination. These 
observations suggest that ubiquitination may depend mainly on lysine accessibility and not 
primary sequence context. However, a factor that seems to enhance the reactivity of a 
lysine is the presence of near-by basic residues. Vicinal lysines could contribute to each 
other´s ubiquitination by depressing pKa and increasing reactivity [140, 153, 154]. 
The specific combination of E2 and E3 enzymes recruited to a substrate dictates the 
chain linkage type. Different ubiquitin modifications adopt diverse three dimensional 
structures which are recognized by specific ubiquitin receptors determining substrates´ fate 
[155-159]. 
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 Because E3s dictate the specificity of the ubiquitination process, they may be 
considered as therapeutic targets [160].  
 
1.15. Types of ubiquitin modifications and substrate fate  
 
The diversity of ubiquitination effects is further enhanced by the multiple ways in which 
ubiquitin can be attached to a protein. The addition of a single ubiquitin to a substrate is 
defined as monoubiquitination. Moreover, several lysine residues in the substrate can be 
tagged with single ubiquitin molecules, termed as multi-monoubiquitination. Finally, 
ubiquitin itself contains seven lysine residues (K6, K11, K27, K29, K33, K48 and K63) 
(Figure 6), which can also be targeted by another ubiquitin molecule in an interactive 
process, known as polyubiquitination, that leads to the formation of a ubiquitin chain 
attached to a single lysine. It is now clear that different types of ubiquitination are involved 
in the regulation of different cellular processes [155, 161-165]. Monoubiquitination has 
been implicated in the endocytosis of plasma membrane proteins [129]. In contrast, 
polyubiquitin chains formed via the C-terminal glycine and K48 or K11 of two ubiquitins 
have a well-characterized role in targeting proteins for degradation by the 26S proteasome 
[166, 167], whereas ubiquitin chains formed through K63 are involved in other cellular 
functions including DNA repair, cell signaling and endocytosis [168].  
 
1.16. Ubiquitin-mediated degradation pathways 
 
There are three major degradation pathways in mammalian cells: the proteasome, the 
lysosome and the autophagosome and it is now well demonstrated that ubiquitin is 
involved in all of them (Figure 9) [168]. Factors that may influence the route of 
degradation of a particular protein include chain length and linkage type, as well as the 
nature of the E2 and/or E3 enzymes involved [168].  
The ubiquitin-proteasome degradation pathway is a major route for protein 
degradation. The proteasome is a multiprotein complex that participates in the degradation 
of cellular proteins. Its components are often referred to by the Svedberg sedimentation 
coefficient denoted S. The 2.5-MDa protein degradation machine 26S comprises a 
proteolytic core particle (CP) 20S and one or two regulatory particle(s) (RP) 19S. The CP 
consists of two outer α rings and two inner β rings, which are made up of seven structurally 
similar α- and β-subunits, respectively. The CP displays caspase-, trypsin-, and 
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chymotrypsin-like activities on the inner surface of the chamber. The RP serves to 
recognize polyubiquitinated proteins and plays a role in the deubiquitination, unfolding, 
and translocation of proteins into the interior of the CP for its destruction [169, 170]. Initial 
studies suggested that K48-linked ubiquitin chains consisting of at least 4 ubiquitin 
molecules were required for 19S recognition and proteasome-mediated degradation [166]. 
Recent studies, however, suggest that other types of chains may also lead to proteasomal 
degradation [165]. 
The lysosomal degradation pathway is prominent in the degradation of plasma 
membrane proteins. Lysosomes are cellular organelles that contain enzymes that mediate 
the degradation of proteins and other biological polymers. Lysosomal enzymes are acid 
hydrolases which require low pH, maintained by the v-ATPase, to be active [171]. 
Independently of the mode of entry, endocytosed proteins are usually delivered to the early 
endosome where sorting occurs. Proteins can be routed from the early endosome to late 
endosomes and lysosomes for degradation, to the trans-Golgi network (TGN), or recycled 
to the plasma membrane [172]. The role of ubiquitin in this degradation pathway consists 
of engaging the internalized protein with the endosomal sorting complexes required for 
transport (ESCRTs). Preferentially K63-linked polyubiqutintination is recognized by 
ubiquitin receptors present in the endocytosis machinery leading to protein internalization 
[168, 173]. 
Autophagy is generally thought to be a non-specific event in which cytosol and 
organelles are degraded. However, there are several cases in which selective autophagy 
take place and ubiquitin plays a role in these events. K27- and K63-linked 
poliubiquitination of autophagosomes can be recognized by specific ubiquitin receptors 
that may lead to regulated lysosome-mediated final degradation [174, 175]. 
Ubiquitin participates in the three major cellular degradation pathways, and the 
targeting of the substrate protein to a particular route is believed to rely on factors such as 
subcellular localization of the substrate, E2s and E3s enzymes, ubiquitin receptors, 
ubiquitin chain length and ubiquitin linkage type. Occasionally, non-canonical degradation 
occurs. For instance, ubiquitinated cytosolic proteins may be degraded by the lysosome 
and cytoplasm-exposed domains of membrane proteins may be degraded by the 
proteasome. Moreover, recent evidence suggests the existence of a proteasome pool 
associated with endosomes that influences protein sorting, highlighting an interplay 
between the proteasomal and lysosomal pathways. 
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Figure 9: Schematic representation of the degradation pathways in which the ubiquitin molecule is 
implicated [168]. 
 
1.17. Work hypothesis and aims 
 
We hypothesize that during ARDS, hypercapnia has negative effects on the re-
establishment of an intact alveolar epithelium by inducing ubiquitin-mediated down-
regulation of the Na,K-ATPase β-subunit. 
 
In the present study we set out to answer the following questions: 
 
What are the effects of hypercapnia on the mechanisms required for the re-
establishment of an intact alveolar epithelium? 
 
- Does hypercapnia negatively affect cell-cell adhesion? 
 
 
Introduction 
23 
 
Which is the molecular mechanism underlying the impaired cell adhesion observed in 
hypercapnia? 
 
- Does hypercapnia induce instability of the Na,K-ATPase β-subunit located at the 
plasma membrane by promoting its endocytosis and/or degradation? 
- Is ubiquitination implicated in Na,K-ATPase β-subunit endocytosis and/or 
degradation? 
- If hypercapnia mediates ubiquitination of the Na,K-ATPase β-subunit, which are 
the molecular players involved? 
- Is it possible to prevent the deleterious effects of hypercapnia on cell adhesion by 
inhibiting the ubiquitination of the Na,K-ATPase β-subunit ? 
 
Understanding the mechanisms by which hypercapnia regulates the β-subunit of the 
Na,K-ATPase and epithelial barrier integrity may provide novel insights into hypercapnia-
induced dysfunction of the alveolar epithelium, as well as the impaired repair of the 
alveolar epithelium associated with hypercapnia during ARDS. Identifying the E3 ligase 
responsible for the  hypercapnia-induced ubiquitination of the Na,K-ATPase β-subunit 
may provide us with a highly specific tool that might be employed in therapies aiming to 
restore alveolar epithelial integrity. 
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2. Material and methods 
 
2.1. General reagents 
 
All chemicals used were of analytical grade purity. Detailed chemicals, reagents and 
consumables are specified along the methodology. 
 
2.2. Alveolar epithelial type II cell lines 
 
Hypercapnia-mediated effects on cell-adhesion and on Na,K-ATPase β-subunit regulation 
were mainly conducted in human A549 cells, an alveolar epithelial cell line in which the 
Na,K-ATPase expression, activity and regulation are characterized and similar to primary 
alveolar epithelial cells [127, 128, 176, 177]. This cell line transfects very efficiently, thus 
facilitating the mechanistic studies. In addition, key experiments on cell adhesion and 
mechanistic studies were validated in primary rat ATII cells which are known to polarize 
and form completely developed intercellular junctions, and are used to study alveolar 
epithelial cell adhesion and barrier properties [85, 178, 179]. 
A549 cells (American Type Culture Collection (ATCC), Manassas, VA; CCL 185) 
are human adenocarcinomic alveolar basal epithelial cells. This cell line was developed 
from cancerous lung tissue in an explanted tumor of a 58-year-old Caucasian male [180]. 
Primary rat ATII cells are ATII cells isolated from rat lung [181]. 
A549 cells stably expressing dog Na,K-ATPase β-subunit fused to yellow 
fluorescence protein (YFP) were employed in some experiments (A549-β1-YFP cells; a 
generous gift from Dr. Sznajder and Dr. Dada, Northwestern University, Chicago, IL, 
USA). 
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2.3. Drugs 
 
Drug Application Concentration Vehicle Company  
MG-132 proteasomal 
inhibitor 
20 µM DMSO Calbiochem 
Chloroquine lysosomal 
inhibitor 
100 µM water Sigma-Aldrich 
E-64 lysosomal 
inhibitor 
10 µM water Calbiochem 
N-ethilmaneimide 
(NEM) 
deubiquitination 
inhibitor 
5 mM ethanol Sigma-Aldrich 
Cycloheximide (CHX) protein synthesis 
inhibitor 
1.7 mM water Sigma-Aldrich 
Bisindolylmaleimide I, 
Hydrochloride (BIS) 
PKC inhibitor 10 µM DMSO Cell Signaling 
 
Table I: Chemical agents applied in cellular experiments. 
 
2.4. Primers 
 
All primers were synthesized by METABION (Martinsried, Germany). 
 
Construct                                                    Primer 
WT Forward: 5´ATAGGATCCGTAATGGCCCGCGGGAAAGCCAAG3´  
Reverse: 5´CTGGAATTCGCTCTTAACTTCAATTTTTACATC3´ 
K5R 5´GGATCCGTAATGGCCCGCGGGAGAGCCAAGGAGGAGGGCAGCTGG3´ 
K7R 5´GGATCCGTAATGGCCCGCGGGAAAGCCAGGGAGGAGGGCAGCTGG3´ 
K5RK7R 5´GGATCCGTAATGGCCCGCGGGAGAGCCAGGGAGGAGGGCAGCTGG3´ 
K13RK14R 5´GAGGAGGGCAGCTGGAGGAGATTCATCTGGAACTCAG3´ 
K21RK22R 5´CATCTGGAACTCAGAGAGGAGGGAGTTTCTGGGCAG3´ 
S11A 5´GCCCGCGGGAAAGCCAAGGAGGAGGGCGCCTGGAAGAAATTCATCTGG3´ 
S11D 5´GCCCGCGGGAAAGCCAAGGAGGAGGGCGACTGGAAGAAATTCATCTGG3´  
 
Table II: Primers employed for cloning and site-directed mutagenesis. 
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2.5. Plasmids 
 
Plasmid Insert Description Provider 
pcDNA 3.1 V5-His Na,K-ATPase β1-subunit, 
H. sapiens 
Invitrogen 
pRK5-HA-Ubiquitin-wt Wild type (wt) ubiquitin, H. 
sapiens 
Addgene (plasmid 
17608) [182] 
pEBG-TRAF2-GST TRAF2, H. sapiens Addgene (plasmid 
21586) [183] 
 
Table III: Plasmids employed in cell transfection experiments 
 
2.6. siRNA 
 
siRNA Provider pmols/transfection 
siPKC-ζ Cell Signaling 120  
siTRAF2 Santa Cruz 120  
 
Table IV: siRNAs employed for cell transfection experiments. 
 
2.7. Synthetic peptides 
 
All synthetic peptides were designed by our laboratory and synthesized by BIOMATIK 
(Delaware, USA). All peptides were labeled with biotin in the N-terminal. 
 
Construct Peptide 
WT Biotin-MARGKAKEEGSWKKFIWNSEKKEFLGRTGGSWFK 
S11D Biotin-MARGKAKEEGDWKKFIWNSEKKEFLGRTGGSWFK 
S19D Biotin-MARGKAKEEGSWKKFIWNDEKKEFLGRTGGSWFK 
S31D Biotin-MARGKAKEEGSWKKFIWNSEKKEFLGRTGGDWFK 
 
Table V: N-terminal biotinylated synthetic peptides employed in in vitro studies. 
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2.8. Antibodies 
 
Antibody Dilution 
(application) 
Company name 
Anti-Na,K-ATPase β1-subunit mouse 
monoclonal IgG2a (Clone M17-P5-F11) 
1:10000 (IB) 
1:250 (IP) 
1:40 (IF) 
Thermo Scientific 
Anti-E-cadherin rabbit polyclonal IgG (H-
108) 
1:200 (IB) Santa Cruz 
Biotechnology 
Anti-Actin rabbit polyclonal affinity 
purified antibody 
1:10000 (IB) 
 
Sigma-Aldrich 
Anti-Ub mouse monoclonal IgG1 against 
mono and poliubiquitination (Clone P4D1) 
1:10000 (IB) Santa Cruz 
Biotechnology 
Anti-V5 rabbit polyclonal IgG 1:250 (IP) Sigma-Aldrich 
Anti-V5 mouse monoclonal IgG 1:2000 (IB) Invitrogen 
Anti-HA.11 mouse monoclonal IgG1 
(Clone 16B12) 
1:5000 (IB) Covance 
Anti-GFP mouse IgG1 (clones 7.1 and 
13.1)  
1:1000 (IB) 
1:50 (IP) 
Roche Diagnostic 
Anti-PKC-ζ mouse monoclonal IgG2 (H-1) 1:200 (IB) 
1:40 (IF) 
Santa Cruz 
Biotechnology 
Anti-TRAF2 rabbit polyclonal IgG (C-20) 1:200 (IB) Santa Cruz 
Biotechnology 
Anti-mouse IgG (H+L) rabbit polyclonal 
IgG HRP-conjugated 
1:5000 (IB) Thermo Scientific 
Anti-rabbit IgG goat polyclonal IgG HRP-
conjugated 
1:2500 (IB) Cell Signaling 
Anti-mouse IgG (H+L) rabbit polyclonal 
IgG FITC-conjugated 
1:100 (IF) Thermo Scientific 
 
Table VI: Antibodies used for Western immunoblotting (IB), immunofluorescence (IF) and 
immunoprecipitation (IP) analysis. 
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2.9. Isolation of alveolar epithelial type II cells from rat lungs 
 
The lungs from male Sprague Dawley rats (200–250 g) were perfused at 37°C with: 
 
Solution A: 0.9% NaCl 
0.1% glucose 
30 mM HEPES 
6 mM KCl 
0.1 mg/ml streptomycin sulfate 
0.2 mg/ml penicillin G 
0.07 mg/ml EGTA 
3 mM Na2HPO4 
3 mM NaH2PO4, pH 7.4 
 
Then, the lungs were lavaged 8-10 times at 37°C using: 
 
Solution B:  3 mM MgSO4 
1.5 mM CaCl2 
 
Perfusion was followed by lung digestion by elastase (3 U/ml in solution A) at 37°C and 
incubating for 12-14 minutes. This step was repeated twice. After chopping with scissors 
for several times, the cell suspension was mixed with 100 mg/ml DNase I, incubated for 5 
minutes at 37°C with gentle rotation, and filtered through 160 and 37 mm nylon mesh 
once, and 15 mm nylon mesh twice. The cells were incubated for 30 minutes at 37°C in rat 
IgG-coated polystyrene 100 mm Petri dishes (1.5mg rat IgG/dish). The unattached cells 
were centrifuged at 250 xg for 8 minutes and resuspended in: 
 
Solution C: RPMI 1640 medium containing 
25 mM HEPES 
1% FBS 
100 mg/ml DNase I  
 
at a concentration of 10 ~ 20 ×106 cells/ml. To remove the remaining macrophages, the 
cells were incubated with rat IgG (40 mg/ml) at room temperature for 15 minutes with 
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gentle rotation. After being washed twice with solution C, the cells were incubated with 
sheep anti-rat IgG magnetic beads (100 ml/rat) for 15 minutes at 41°C. The beads were 
removed by a magnetic device. To remove leukocyte and ATI contaminations, the cells 
were incubated with anti- LC (40 mg/ml) and rabbit anti-rat T1a (40 mg/ml) at 41°C for 40 
minutes, followed by incubation with goat anti-mouse IgG Dynabeads (100 ml/rat) and 
goat anti-rabbit IgG BioMags beads (500 ml/rat). Finally, primary ATII cells were plated 
as needed and used in day 3. 
 
2.10. Cell culture 
 
Cells were incubated in a Haereus cell culture incubator (Haereus Instruments, Hanau, 
Germany) at a temperature of 37°C, 80-90% relative humidity and 5% carbon dioxide in 
air atmosphere. A549 cells were cultured in Dulbecco´s modified Eagle medium high 
glucose (DMEM High Glucose; PAA Laboratories, Egelsbach, Germany) containing 10% 
[vol/vol] fetal bovine serum (FBS; PAA Laboratories, Egelsbach, Germany), 100 U/ml 
penicillin, and 100 µg/ml streptomycin (both from PAN-Biotech, Aidenbach, Germany). 
Cells were plated in 100 mm tissue culture dishes (Cellstar; Greiner Bio-One, 
Frickenhausen, Germany). For subculturing, cells were rinsed in Dulbecco´s Phosphate-
Buffered Saline (DPBS; PAA Laboratories, Egelsbach, Germany) twice, incubated 5 
minutes in 0.25% trypsin-EDTA (PAN-Biotech, Aidenbach, Germany) to allow cell 
detachment, resuspended in culture medium and seeded in a ratio 1:10 in 100 mm dishes 
for further subculturing. For experiments, cells from passage 3 to 15 were employed and 
plated on tissue culture dishes or cover slips. 
 
2.11. DNA constructs generation 
 
2.11.1. DNA construct strategy 
 
For the development of the project we cloned the coding region of Na,K-ATPase β-subunit 
in a mammalian expression plasmid pcDNA 3.1 V5-His (Figure 10). This plasmid 
contains a strong promoter for high-level expression in mammalian cells (cytomegalovirus 
(CMV) promoter) and a V5 epitope tag for easy detection with a monoclonal antibody.  
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Figure 10: pcDNA3.1/V5-His A Multiple Cloning Site 
 
The human Na,K-ATPase β-subunit mRNA sequence was obtained from the 
Genbank sequence database (Gene ATP1B1; NCBI Reference Sequence: NM_001677.3; 
GI: 49574487). In order to insert the complete human Na,K-ATPase β-subunit coding 
region into pcDNA 3.1 V5-His plasmid specific primers were designed containing 
restriction sites for BamHI and EcoRI to clone the protein unidirectionally:  
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Forward primer containing BamHI restriction site:  
5´ ATAGGATCCGTAATGGCCCGCGGGAAAGCCAAG 3´ 
 
Reverse primer containing EcoRI restriction site:   
5´ CTGGAATTCGCTCTTAACTTCAATTTTTACATC 3´ 
 
The underlined sequences show the position of the restriction sites for BamHI and 
EcoRI. The sequences in red correspond to β-subunit coding sequence. The stop codon was 
removed in order to add the fusion V5 tag in frame with the c-terminal domain of the 
protein. 
 
Amplified fragment (122-1030 bp): 
5´ATGGCCCGCGGGAAAGCCAAGGAGGAGGGCAGCTGGAAGAAATTCATCTGG
AACTCAGAGAAGAAGGAGTTTCTGGGCAGGACCGGTGGCAGTTGGTTTAAGAT
CCTTCTATTCTACGTAATATTTTATGGCTGCCTGGCTGGCATCTTCATCGGAAC
CATCCAAGTGATGCTGCTCACCATCAGTGAATTTAAGCCCACATATCAGGACC
GAGTGGCCCCGCCAGGATTAACACAGATTCCTCAGATCCAGAAGACTGAAATT
TCCTTTCGTCCTAATGATCCCAAGAGCTATGAGGCATATGTACTGAACATAGTT
AGGTTCCTGGAAAAGTACAAAGATTCAGCCCAGAGGGATGACATGATTTTTGA
AGATTGTGGCGATGTGCCCAGTGAACCGAAAGAACGAGGAGACTTTAATCATG
AACGAGGAGAGCGAAAGGTCTGCAGATTCAAGCTTGAATGGCTGGAAATTGCT
CTGGATTAAATGATGAAACTTATGGCTACAAAGAGGGCAAACCGTGCATTATT
ATAAAGCTCAACCGAGTTCTAGGCTTCAAACCTAAGCCTCCCAAGAATGAGTC
CTTGGAGACTTACCCAGTGATGAAGTATAACCCAAATGTCCTTCCCGTTCAGTG
CACTGGCAAGCGAGATGAAGATAAGGATAAAGTTGGAAATGTGGAGTATTTTG
GACTGGGCAACTCCCCTGGTTTTCCTCTGCAGTATTATCCGTACTATGGCAAAC
TCCTGCAGCCCAAATACCTGCAGCCCCTGCTGGCCGTACAGTTCACCAATCTTA
CCATGGACACTGAAATTCGCATAGAGTGTAAGGCGTACGGTGAGAACATTGGG
TACAGTGAGAAAGACCGTTTTCAGGGACGTTTTGATGTAAAAATTGAAGTTAA
GAGC 3´ 
 
One of the aims of the project consisted of studying hypercapnia effects on 
phosphorylation and ubiquitination of Na,K-ATPase β-subunit. In order to identify the 
amino acids involved in these phosphorylation and ubiquitination processes, we created 
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protein variants by adding point mutations to the original Na,K-ATPase β-subunit C-
terminal V5-tagged (wt) construct with the Quick Change Mutagenesis Kit (Stratagene, La 
Jolla, California, USA). We only focused on the intracellular domain of Na,K-ATPase β-
subunit because post-translational modifications would occur in that region. The strategy 
employed to study the amino acids involved in ubiquitination consisted of changing lysines 
(K) to arginines (R). In order to identify the amino acids involved in serine 
phosphorylation, serines (S) were changed to alanine (A) to prevent phosphorylation, or to 
aspartate (D) to mimic phosphorylation. Combination of multiple mutations was done by 
using plasmids already containing Na,K-ATPase β-subunit mutations as templates for 
additional desired point mutations. Forward primers employed in the mutagenesis are 
displayed in the table II (reverse primers consisting of the reverse complement of the 
forward primer sequence are not shown in the table). Variants employed in this work are: 
K5R, K7R, K5/7R, K13/14R, K21/22R, S11A and S11D. 
 
2.11.2. RNA isolation 
 
Total RNA was isolated from A549 cells with the use of the commercial RNAasy Minikit 
(QIAGEN, Hilden, Germany) and QIAshredder columns (QIAGEN, Hilden, Germany). 
Briefly, A549 cells were plated in 60 mm cell culture dishes and allow to reach 
confluency. Cells were rinsed with DPBS twice and lysed directly with RLT lysis buffer 
containing 1% β-mercaptoethanol. In order to reduce the viscosity of the cell lysate, 
homogenization was done by loading the cell lysate into a QIAshredder column. The 
homogenate was collected from the column by 2 minutes of centrifugation at 14000 xg and 
mixed with 70% ethanol in order to provide appropriate binding conditions to the RNeasy 
Mini spin column. Once in the column, RNA was preferentially bound to the silica 
column, whereas DNA and proteins were removed by sequential washes. Finally RNA was 
eluted from the column with RNAse free water. Samples were quantified with the 
Nanodrop (Thermo Fisher Scientific, Waltham, Massachusetts, USA) and approximately 
30 µg of RNA per sample were recovered and stored at -70°C till use.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
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2.11.3. cDNA synthesis 
 
In order to obtain copy DNA (cDNA), total RNA was reversed transcript employing 
iScript cDNA Synthesis Kit (Biorad, Hercules, California, USA). To conduct the cDNA 
synthesis we prepared a reaction mix as shown in Table VII. 
  
Components Volume per 20 µl Reaction 
5x iScript reaction mix 4 µl 
iScript reverse transcriptase 1 µl 
nuclease-free water 14 µl 
RNA template (1 µg/ul total RNA) 1 µl 
  
Table VII: Reverse transcription reaction mix. 
 
We conducted the reverse transcription reaction in a thermocycler (Thermo Fisher 
Scientific, Waltham, Massachusetts, USA). We employed a program that involved 5 
minutes at 25°C, 30 minutes at 42°C and 5 minutes at 85°C. cDNA was stored at -20°C till 
use. 
 
2.11.4. PCR 
 
DNA amplification was done by the use of Q5 Hot Start High-Fidelity DNA Polymerase 
(Biolabs, Massachusetts, USA). The reaction mix is shown in Table VIII.  
 
Components Volume per 50 µl Reaction 
5x Q5 Reaction Buffer (Biolabs) 10 µl 
dNTP Mix, 10 mM each (Thermo Scientific) 1 µl 
10 µM Forward Primer (Metabion) 2.5 µl 
10 µM Reverse Primer (Metabion) 2.5 µl 
template DNA (1µg/ul cDNA) 2 µl 
Q5 Hot Start High-Fidelity DNA Polymerase (Biolab) 0.5 µl 
nuclease-Free Water 31.5 µl 
 
Table VIII: PCR reaction mix. 
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In order to obtain the DNA amplification we used the following thermocycling 
conditions in a thermocycler (Thermo Fisher Scientific, Waltham, Massachusetts, USA): 
 
Initial Denaturation   5 minutes 25°C 
Denaturation   30 seconds 95°C 
Annealing   1 minute 60°C     35 cycles 
Extension   1 minute 72°C 
Final extension  7 minutes 72°C 
 
 PCR products were purified as described below and stored at -20°C till use. 
 
2.11.5. DNA purification 
  
PCR products as well as plasmids and DNA fragments digested by restriction enzymes 
were all purified by the use of Wizard SV Gel and PCR Clean-Up System (Promega, 
Fitchburg, Wisconsin, USA). Briefly, equal volume of membrane binding solution was 
added to the DNA solution and loaded into the SV Minicolumn and centrifuged 1 minute 
at 16000 xg. DNA fragments from 100 bp to 10 kb were preferentially bound to this 
column, whereas nucleotides, primers, enzymes were washed away from the DNA 
mixtures by sequential washes with washing buffers provided by the kit. Finally DNA was 
eluted with 30 µl nuclease-free water with approximately 98% efficiency. DNA was 
quantified with Nanodrop and stored at -20°C till use.  
 
2.11.6. DNA digestion 
 
Our aim was to clone the complete human Na,K-ATPase β-subunit coding region into 
pcDNA 3.1 V5-His plasmid unidirectionally and in frame with V5 tag. As stated before, 
specific primers containing BamHI and EcoRI restriction enzyme sites were used to 
amplify Na,K-ATPase β-subunit coding region by PCR, obtaining a DNA fragment 
flanked by BamHI on 5´and by EcoRI on 3´. Then, DNA fragment and plasmid were 
digested with these enzymes and ligated. This strategy allowed us to control the 
appropriate direction of the insert required for Na,K-ATPase β-subunit protein expression. 
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For the restriction enzyme digestion FastDigest BamHI and EcoRI (Thermo Fisher 
Scientific, Waltham, Massachusetts, USA) were employed. These enzymes were suitable 
for double digestions as they were fully functional in equal buffer conditions. For the DNA 
insert, 100 µl of PCR products were purified as described before, eluted in 30 µl of 
nuclease-free water and used in the digestion reaction. 1 µg of plasmid was used in the 
digestion reaction. The reaction mixture, prepared according to the manual instructions, 
was incubated 30 minutes at 37°C in water bath and inactivated 5 minutes at 80°C in a 
heating block. Digestion products were purified as described before and stored at -20°C till 
use. 
 
2.11.7. DNA ligation 
 
In order to insert complete human Na,K-ATPase β-subunit coding region into pcDNA 3.1 
V5-His plasmid digested and purified DNA insert and plasmid were ligated employing T4 
DNA Ligase (Promega, Fitchburg, Wisconsin, USA). For the ligation reaction we used an 
insert/vector ratio of 3/1 and followed the provider recommendations. The reaction was 
allowed to proceed overnight at 4°C. Negative controls were included in order to assess the 
proportion of uncutted plasmid (T4 DNA Ligase was omitted) and plasmid cutted only 
with one of the restriction enzymes (insert was omitted).  
 
2.11.8. Transformation of competent bacteria 
 
JM109 competent bacteria (Promega, Fitchburg, Wisconsin, USA) were thawn on ice for 
5-10 minutes. For transformation, 50 µl of JM109 cells suspension was added to 10 µl of 
the ligation reaction and incubated during 30 minutes on ice. Then a heat shock (90 
seconds at 42°C in water bath) was applied to the cells and immediately after cells were 
placed on ice for 5 minutes. After adding 100 µl of LB Broth medium (Luria-Bertani Broth 
Medium, Invitrogen, Karlsruhe, Germany), bacteria were allowed to recover during 30 
minutes at 37°C with 250 rpm agitation. Transformation reaction was plated onto selective 
bacterial LB agar (Luria-Bertani Agar Medium, GIBCO, Invitrogen, Karlsruhe, Germany) 
containing 100 µg/ml ampicillin (Sigma, St.Luis, USA). 
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2.11.9. Colony PCR 
 
In order to screen for positive clones, PCRs from liquid cultures were performed. Minor 
modifications were done to the PCR protocol described before. 2 µl of bacteria liquid 
culture were used as a template and the initial denaturalization step was done for 10 
minutes in order to completely lyse bacteria. 
 
2.11.10. Agarose gel electrophoresis 
 
PCR reactions were analyzed on 1% agarose gels (Invitrogen, Karlsruhe, Germany) in  
 
1x TAE Buffer:  40 mM Tris 
20 mM acetic acid 
1 mM EDTA (pH 8.0)  
 
containing 1% (v/v) SYBRSafe (Invitrogen, Karlsruhe, Germany). Samples were mixed 
with loading buffer 6x (Thermo Fisher Scientific, Waltham, Massachusetts, USA). The gel 
was run in 1x TAE buffer for 30 minutes at 100 V. Gene Ruler High Range DNA Ladder 
(Thermo Fisher Scientific, Waltham, Massachusetts, USA) was included. DNA bands were 
visualized under UV Transilluminator (Biorad, Hercules, California, USA). 
 
2.11.11. Small scale plasmidic DNA isolation 
 
Plasmid DNA was prepared at a small scale using PeqGOLD Plasmid Mini Kit (Peqlab, 
Erlangen, Germany). Briefly, a single colony was picked using a sterile tip and used to 
inoculate 7 ml of selective LB medium containing 100 µg/ml ampicillin. Bacteria cultures 
were incubated overnight at 37°C with constant agitation at 250 rpm. Bacteria pellet was 
collected by centrifugation at 5000 xg for 10 minutes. Cell pellet was resuspended in 250 
µl buffer P1 (containing RNase A). Then bacteria were lysed by adding 250 µl buffer P2 
SDS/alkaline solution. Genomic DNA was precipitated when 350 µl of buffer P3 was 
added, and separated from the solution by 10 minutes centrifugation at 10000 xg. 
Supernatant was loaded into the PerfectBind DNA Column which consist of a silica 
column that specifically binds DNA. By sequential washes protein and RNA were 
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removed. Finally, plasmidic DNA was eluted from the column with 30 µl Nuclease-Free 
water, quantified with Nanodrop and stored at -20°C till use.  
 
2.11.12. Large scale plasmidic DNA isolation 
 
Plasmid DNA was prepared at a big scale using EndoFree Plasmid Purification Maxi Kit 
(Qiagen, Hilden, Germany) which has the advantage of giving high yields of plasmidic 
DNA and free of bacteria toxins that may result toxic for mammalian cells in cell 
transfection protocols. 
Briefly, 100 ml of selective LB medium containing 100 µg/ml ampicillin were 
inoculated with 200 µl of bacteria culture containing the plasmid of interest. Bacteria 
cultures were incubated overnight at 37°C with constant agitation at 250 rpm. Bacteria 
pellet was collected by centrifugation of 50 ml centrifuge tubes at 6000 xg for 15 minutes. 
Cell pellet was resuspended in 10 ml buffer P1 (containing RNase A). Then bacteria were 
lysed by adding 10 ml buffer P2 SDS/alkaline solution. Genomic DNA was precipitated 
when 10 ml of buffer P3 was added, and separated from the solution by filtering in 
QIAfilter Maxi Cartridge. The filtered lysate was loaded into a QIAGEN-Tip Column 
which consist of a silica column that specifically binds DNA. The lysate was allowed to 
enter the resin by gravity flow. By sequential washes protein and RNA were removed and 
plasmidic DNA was eluted from the column with 15 ml of elution buffer. Then, DNA was 
precipitated by centrifugation at 15000 xg for 30 minutes at 4°C after the addition of 10.5 
ml isopropanol. DNA pellet was washed once with 5 ml of 70% ethanol and the pellet was 
redissolved in 100-200 µl of TE (Tris-EDTA solution). Plasmidic DNA was quantified 
with Nanodrop and stored at -20°C till use.  
 
2.11.13. Site-directed mutagenesis 
 
In vitro site-directed mutagenesis is a useful technique for studing protein structure-
function relationship. In order to identify Na,K-ATPase β-subunit amino acids involved in 
ubiquitination and phosphorylation processes we performed point mutations and changed 
intracellular lysines to arginines, and intracellular serines to alanines or aspartates. For this 
purpose, we employed QuickChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, 
California, USA). The basic procedure involves the employment of a plasmid, insert and 
two synthetic primers containing the desired mutation. The oligonucleotide primers, each 
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complementary to opposite strands of the vector, are extended during temperature cycling 
by PfuTurbo DNA polymerase which replicates both plasmid strands with high fidelity and 
without displacing the mutant olginonucleotide primers. Incorporation of the primers 
generates a mutated plasmid. The product is treated with Dpn I endonuclease which is 
specific for methylated and hemimethylated DNA and is used to digest the parental DNA 
template (which is methylated when grown in dam+ strains) and therefore to select for 
mutation-containing DNA. Then, the mutated DNA is transformed into XL1-Blue 
supercompetent cells and positive colonies are picked, DNA plasmid isolated and 
sequenced to confirm the presence of the desired mutations. 
The design of mutagenesis primers was done following kit considerations. The 
nucleotides codifying for the amino acids of interested were identified in Na,K-ATPase β-
subunit coding sequence and changed accordingly with the use of the genetic code.  
DNA amplification was done by the use of PfuTurbo DNA polymerase provided by the kit. 
The reaction mix is shown in Table IX. 
  
Components Volume per 25 µl Reaction 
10x Q5 Reaction Buffer 2.5 µl 
dNTP Mix 0.5 µl 
Forward Primer (100 ng/µl, Metabion, HPLC quality) 0.75 µl 
Reverse Primer (100 ng/µl, Metabion, HPLC quality) 0.75 µl 
Template DNA (50 ng/µl cDNA) 0.5 µl 
PfuTurbo DNA Polymerase 0.5 µl 
Nuclease-Free Water 19.5 µl 
 
Table IX: Site-directed mutagenesis PCR reaction mix. 
 
In order to obtain the DNA amplification we used the following thermocycling 
conditions in a thermocycler (Thermo Fisher Scientific, Waltham, Massachusetts, USA): 
 
Initial Denaturation   1 minute   95°C 
Denaturation   30 seconds   95°C 
Annealing   1 minute   55°C     16 cycles 
Extension   6 minutes 30 seconds  68°C 
Hold        4°C 
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PCR products were immediately incubated with 0.5 µl of DpnI during 1 hour at 37 
°C in an incubator, order to digest unmutated parental plasmid DNA. 
DpnI-treated DNA was used to transform XL1-Blue supercompetent cells. Briefly, 
0.5 µl of DpnI-treated DNA was added to 25 µl of bacteria suspension and incubated 
during 30 minutes on ice. Then a heat shock (45 seconds at 42 °C in water bath) was 
applied to the cells and immediately after cells were placed on ice for 5 minutes. After 
adding 250 µl of NZY+ broth medium containing: 
 
NZY+ broth: 40 mM NZ amine pH 7.5 (Roth; Karlsruhe, Germany) 
5g/L yeast extract 
85 mM NaCl (Sigma, St. Luis, USA)  
12.5 mM MgCl2 6H2O (Sigma, St. Luis, USA) 
12.5 mM MgSO4 (1M) (Sigma, St. Luis, USA) 
20 mM Glucose (Sigma, St. Luis, USA) 
 
Bacteria were allowed to recover during 1 hour at 37°C with 250 rpm agitation. 
Transformation reaction was plated onto selective bacterial LB agar (Luria-Bertani Agar 
Medium, Invitrogen, Karlsruhe, Germany) containing 100 µg/ml ampicillin (Sigma-
Aldrich, St. Luis, USA). Usually, two positive colonies per mutagenesis reaction were 
picked, grown in selective liquid media and used to isolate DNA. Plasmidic DNA was sent 
to sequence in order to confirm the presence of the desired mutations. 
 
2.11.14. DNA sequencing 
 
Incorporation of the complete human Na,K-ATPase β-subunit coding region into pcDNA 
3.1 V5-His plasmid in frame with V5 tag as well as nucleotide sequence accuracy were 
both confirmed by DNA sequencing. With this purpose, 2 µg of plasmid DNA previously 
isolated with PeqGOLD Plasmid Mini Kit were sent to sequence to Seqlab Company 
(Göttingen, Germany). Clones were sequenced using T7 promoter and BHG reverse 
universal primers. Sequences obtained were aligned with a reference sequence (Genbank 
Database) employing BLAST (Basic Local Alignment Search Tool) bioinformatic 
program. 
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2.11.15. Glycerol stock  
 
For storage of recombinant clones, 500 µl overnight bacterial culture were mixed with 500 
µl of 80% glycerol and frozen at -80°C freezer. 
 
2.12. DNA transfection of A549 cells 
 
For DNA transfection with V5-Na,K-ATPase β1-subunit wt  (V5-β1 wt) and V5-β1 
variants, A549 cells were plated on 60 mm tissue culture dishes at 60% confluency. On the 
day of transfection, 12 µl of lipofectamine 2000 (Invitrogen, Karlsruhe, Germany) were 
diluted in 500 µl of DMEM media and preincubated 5 minutes before adding 4 µg of 
plasmid DNA. After 30 minutes incubation, the mix was added onto the cells containing 2 
ml of growing media. Experiments were performed 18 hours later. For DNA cotransfection 
with V5-β1 wt and V5-β1 variants and HA-Ubiquitin wt and variants, A549 cells were 
plated on 100 mm tissue culture dishes at 60% confluency. On the day of transfection, 42 
µl of lypofectamine 2000 (Invitrogen, Karlsruhe, Germany) were diluted in 2.7 ml of 
optiMEM media and preincubated 5 minutes before adding 4 µg of V5-β1 plasmid DNA 
and 10 µg of HA-ubiquitin plasmid DNA. After 30 minutes incubation, the mix was added 
onto the cells. 4 hours later transfection solution was removed and fresh complete media 
was added to cells. Experiments were performed 18 hours later. Controls with empty 
vector were included. 
 
2.13. siRNA transfection of A549 cells 
 
A549 cells were plated on 60 mm tissue culture dishes at 60% confluency. On the day of 
transfection, 17 µl of lipofectamine RNAiMax Reagent (Invitrogen, Karlsruhe, Germany) 
were diluted in 250 µl of optiMEM media and 17 µl of siRNA (10 µM stock) were diluted 
in 250 µl of optiMEM media. After 5 minutes preincubation, solutions were mixed and 
incubated for additional 30 minutes, after which the mix was added onto the cells containg 
2 ml of growing media. For the knock-down of TRAF2, experiments were performed 48 
hours later and for the knock-down of PKC-ζ, experiments were performed 72 hours later. 
Controls with scramble siRNA were included. 
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2.14. Plasmidic DNA nucleofection of A549 cells and rat primary ATII cells 
 
For DNA transfection with V5-β1 wt and variants, immediately after isolation, ATII cells 
were plated on 60 mm tissue culture dishes at 40% confluency. The next day, cells were 
harvested as usual. 1x106 cells were resuspended in 100 µl of the Nucleofector solution 
indicated for primary cultures and 4 µg of DNA was added. Immediately cells were placed 
in the cuvette and pulsed with the indicated cell-type specific Nucleofector program 
(Lonza Company). After 10 minutes incubation cells were plated in complete DMEM 
media. Experiments were conducted 2 days after transfection. A549 nucleofection was 
conducted similarly, but employing the indicated cell-line solution and program. 
 
2.15. Protocols of cellular experiments 
 
2.15.1. Hypercapnia treatments 
 
In order to study hypercapnia effects on cells different solution were employed, in which 
the buffering capacity of the medium was modified by changing the initial pH with Tris to 
obtain a pH of 7.4 at 40 mmHg (Control, “Ctrl”) and 110 mmHg (Hypercapnia, “CO2”). 
 
Normocapnia Media (Ctrl): 3 ml DMEM High Glucose with FCS 10% [vol/vol] 
1 ml Ham´s F-12 medium (GIBCO, Invitrogen, 
Karlsruhe, Germany) 
0.5 ml Tris base solution 0.5 M (pH 7.4) 
 
Hypercapnia Media (CO2): 3 ml DMEM High Glucose FCS 10% [vol/vol] 
1 ml Ham´s F-12 medium 
0.5 ml Tris base solution 0.5 M (pH 10) 
 
The desired CO2 and pH levels were achieved by equilibrating medium overnight in 
a humidified chamber (C-Chamber, BioSpherix Ltd., NY, USA). The atmosphere of the C-
Chamber was controlled with a PROCO2 carbon dioxide controller (BioSpherix Ltd. NY, 
USA). In this chamber, cells were exposed to the desired pCO2 while maintaining 21% O2, 
balanced with N2. Prior CO2 exposure, pH, pCO2, and pO2 levels in the media were 
measured with a blood gas analyzer (Rapidlab, Siemens, Erlangen, Germany). 
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2.15.2. Na,K-ATPase β-subunit endocytosis studies 
 
A549 cells transfected with V5-β1 wt and variants were exposed to normocapnia or 
hypercapnia media for 30 minutes at 37°C in the humidified C-Chamber. Cells were 
washed three times with PBS Ca+ Mg+ (PAA Laboratories, Egelsbach, Germany) and cell 
surface proteins were labeled for 20 minutes using 1 mg/ml cell-impermeable EZ-link 
NHS-SS-biotin (Thermo Fisher Scientific, Waltham, Massachusetts, USA) in PBS Ca+ 
Mg+. Cells were rinsed for 10 minutes three times with PBS Ca+ Mg+ containing 100 mM 
glycine to quench unreacted biotin. Cells were lysed in modified radioimmunoprecipitation 
buffer: 
 
mRIPA  50 mM Tris-HCl, pH 8 
150 mM NaCl 
1% NP-40 
1% sodium deoxycholate 
protease inhibitor cocktail 
  
Protein extract were quantified by Bradford technique (see Section 2.17.) and 150-
400 µg of protein were rotated overnight at 4°C with in the presence of streptavidin-
agarose beads. (Thermo Fisher Scientific, Waltham, Massachusetts, USA). The beads were 
thoroughly washed as indicated: 
 
Solution 1 (1x): 150 mM NaCl 
50 mM Tris, pH 7.4 
5 mM EDTA 
 
Solution 2 (2x): 500 mM NaCl 
50 mM Tris, pH 7.4 
5 mM EDTA 
 
Solution 3 (3x): 500 mM NaCl 
20 mM Tris, pH 7.4 
0.2% BSA 
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Tris 10 mM pH 7.4 (1x) 
 
and then resuspended in 30 µl of: 
 
Laemmli Sample Buffer 2x [184]: 100 mM Tris, 6.8 pH  
4% SDS  
0.02% bromophenol blue 
20% glycerol 
 
containing 10% β-mercaptoethanol. Samples were incubated for 30 minutes at 37°C in the 
heating block. Proteins were analyzed by SDS-PAGE and IB (See Section 2.18.).  
 
2.15.3. Cell surface Na,K-ATPase β-subunit degradation studies  
 
Cell surface proteins from A549 cells were labeled for 10 minutes using 1 mg/ml cell-
impermeable EZ-link NHS-SS-biotin in PBS Ca+ Mg+ (“pulse” with cell impermeable 
biotin). Cells were rinsed for 10 minutes three times with PBS Ca+ Mg+ containing 100 
mM glycine to quench unreacted biotin. Cells were exposed to normocapnia or 
hypercapnia media for different time points at 37°C in the humidified C-Chamber (“chase” 
under normocapnic or hypercapnic conditions). Cells were washed three times with PBS 
Ca+ Mg+ and lysed in mRIPA buffer. Protein extracts were quantified by Bradford 
technique and 400 µg of protein were rotated overnight at 4°C in the presence of 
streptavidin-agarose beads. The beads were thoroughly washed as indicated before and 
then resuspended in 30 µl of Laemmli sample buffer solution 2x containing 10% β-
mercaptoethanol. Samples were incubated for 30 minutes at 37°C in heating block. 
Proteins were analyzed by SDS-PAGE and IB.  
 
2.15.4. Total Na,K-ATPase β-subunit degradation studies 
 
A549 cells were incubated with cycloheximide (CHX), an inhibitor of protein synthesis, 
for different time points at 37°C in the humidified C-Chamber, after which cells were 
rinsed three times with PBS Ca+ Mg+ and lysed in mRIPA buffer. Protein extract were 
quantified by Bradford technique and 40 µg of protein resuspended in 1x Laemmli sample 
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buffer solution containing 5% β-mercaptoethanol. Samples were incubated for 30 minutes 
at 37°C in a heating block. Proteins were analyzed by SDS-PAGE and IB. 
 
2.15.5. Cell surface Na,K-ATPase β-Subunit ubiquitination studies 
 
Cell surface proteins from A549 cells were labeled for 20 minutes using 1 mg/ml cell-
impermeable EZ-link NHS-SS-biotin in PBS Ca+ Mg+. Cells were rinsed for 10 minutes 
three times with PBS Ca+ Mg+ containing 100 mM glycine to quench unreacted biotin. 
Cells were exposed to normocapnia or hypercapnia media for different time points at 37°C 
in the humidified C-Chamber. Cells were washed three times with PBS Ca+ Mg+ and lysed 
in mRIPA buffer. Then 1% Triton x100 and 0.1% SDS were added to 800-1000 µg of 
protein in 500 µl final volume and precleared with protein A/G PLUS agarose (Santa Cruz 
Biotechnology, California, USA). Precleared lysates were rotated with the indicated 
antibodies for 1 hour at 4°C. Then antigen-antibody complexes were immunoprecipitated 
by adding 50 µl of protein A/G and rotated overnight at 4°C. Immunoprecipitates were 
washed 5 times with mRIPA buffer containing protease inhibitors. Agarose beads were 
resuspended in 30 µl of the following buffer: 
 
Resuspension Buffer:  25 mM Tris HCl pH 6.8 
NEM 
Protease Inhibitor cocktail 
1% SDS  
 
and boiled for 5 minutes. Beads were pelleted by centrifuging 1 minute at 14000 xg and 
supernatant was adjusted to 300 µl final volume with mRIPA buffer containing protease 
inhibitors and NEM. Then, 60 µl of streptavidin-agarose beads were rotated overnight at 
4°C. The beads were thoroughly washed as indicated before and then resuspended in 30 µl 
of Laemmli sample buffer solution 2x containing 20% β-mercaptoethanol. Samples were 
boiled for 10 minutes in heating block. Proteins were analyzed by SDS-PAGE and IB.  
 
2.15.6. Total Na,K-ATPase β-Subunit ubiquitination studies 
 
A549 cells were exposed to normocapnia or hypercapnia media for 15 minutes at 37°C in 
the humidified C-Chamber. Cells were washed three times with PBS Ca+ Mg+ and lysed in 
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mRIPA buffer. Then 1% Triton x100 and 0.1% SDS were added to 800-1000 µg of protein 
in 500 µl final volume and precleared with protein A/G PLUS Agarose. Precleared lysates 
were rotated with the indicated antibodies for 1 hour at 4°C. Then antigen-antibody 
complexes were immunoprecipitated by adding 50 µl of protein A/G and rotated overnight 
at 4°C. Immunoprecipitates were washed 5 times with mRIPA buffer containing protease 
inhibitors. Agarose beads were resuspended in 2x Laemmli sample buffer solution 
containing 20% β-mercaptoethanol. Samples were boiled for 10 minutes in the heating 
block. Proteins were analyzed by SDS-PAGE and IB. 
  
2.15.7. In vitro protein interaction studies  
 
A549 cells were exposed to normocapnia or hypercapnia media for 15 minutes at 37°C in 
the humidified C-Chamber. Cells were washed three times with PBS Ca+ Mg+ and lysed in: 
 
Co-IP buffer: 20 mM HEPES pH 7.4   
150 mM NaCl 
0.5% NP-40 
2 mM EDTA 
2 mM EGTA 
5% glycerol 
Phosphatase/protease inhibitor cocktail  
 
The interaction mixture was prepared with 500 µg of protein total lysate and 2.5 
nmol of a biotinylated synthetic peptide containing Na,K-ATPase β-Subunit intracellular 
domain wt or mutated (cyt-β1 peptide wt, S11D, S19D, S31D; see Table V) in a 500 µl 
volume. After overnight incubation, 100 µl streptavidin-agarose beads was added and 
allowed to interact during 2 hours. Biotin-streptavidin complexes were washed 5 times 
with co-IP buffer. Agarose beads were resuspended in 2x Laemmli sample buffer solution 
containing 10% β-mercaptoethanol and 20 mM DTT. Samples were boiled for 10 minutes 
in a heating block. Proteins were analyzed by SDS-PAGE and IB.  
 
2.15.8. Coimmunoprecipitation studies 
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A549 cells were exposed to normocapnia or hypercapnia media for 15 minutes at 37°C in 
the humidified C-Chamber. Cells were washed three times with PBS Ca+ Mg+. Cells were 
lysed by incubating 15 minutes in the presence of co-IP buffer. After pre-clearing, equal 
amounts of proteins (700-1200 µg) were incubated with the indicated antibodies for 1 
hour. 30 µl protein A/G Plus-agarose beads (Santa Cruz Biotechnology) were added and 
incubated overnight at 4°C. The beads were washed 5 times with co-IP buffer and 
resuspended in 2x Laemmli buffer containing 10% β-mercaptoethanol and 20 mM DTT. 
Samples were boiled for 10 minutes in a heating block. Proteins were analyzed by SDS-
PAGE and IB.  
 
2.16. Na,K-ATPase β-subunit in vitro ubiquitination  
 
Endogenous TRAF2 was purified from A549 cells (2 plates of 100 mm per reaction) by 
immunoprecipitation in co-IP buffer containing 2 mM DTT, 0.5% Triton X100, 1 mg/ml 
NEM (Sigma, St. Luis, USA), 5 µM ubiquitin aldehyde (Boston Biochem, Cambridge, 
MA, USA) and 2x protease/phosphatase inhibitor cocktail with anti-TRAF2 antibody. 
A/G-agarose beads were washed 5 times with co-IP buffer and employed as a source of 
ubiquitin E3 ligase. Ubiquitination reactions were carried out at 37°C for 2 hours in 1x 
reaction buffer (Boston Biochem, Cambridge, MA, USA), 1x ATP/ Mg+ (Boston Biochem, 
Cambridge, MA, USA), 100 nM sphingosine-1-phosphate (S1P) (Avati Polar Lipids), 50 
nM E1 UBE1 (Boston Biochem, Cambridge, MA, USA), 150 nM E2 canonical UbcH13 
(in an heterocomplex with Uev1a which lacks E2 active site) (Boston Biochem, 
Cambridge, MA, USA), 100 µg/ml human recombinant ubiquitin (Boston Biochem, 
Cambridge, MA, USA), A/G-agarose beads containing immunoprecipitated TRAF2 and 
biotinylated cyt-β1 wt peptide (see Table V). Reactions were conducted in 100 µl final 
volume with gentle agitation every 10 minutes. Supernatants were recovered and 
resuspended in: 
 
Pull-down Buffer: 20 mM Tris/HCl pH8  
100 mM NaCl 
1 mM EDTA 
0.5% NP-40 
5 µM ubiquitin aldehyde  
2x protease/phosphatase inhibitor cocktail  
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60 µl of streptavidin-agarose beads were employed to pull-down ubiquitinated biotinylated 
cyt-β1 peptides. After ON rotation at 4°C, beads were washed 3 times in pull-down buffer 
and samples were boiled in 2x Laemmli sample buffer solution containing 10% β-
mercaptoethanol for 10 minutes in a heating block. Proteins were analyzed by SDS-PAGE 
and IB.  
 
2.17. Protein quantification 
 
Protein concentration was quantified by Bradford assay (Bio-Rad, Hercules, CA, USA) 
according to the manufacturer instructions. 
 
2.18. SDS-PAGE and Western immunoblotting  
 
Proteins were resolved in 10% polyacrylamide gels (unless stated) and transferred to 
nitrocellulose membranes (Optitran; Schleider & Schuell) using a semi-dry transfer 
apparatus (Bio-Rad, Hercules, CA, USA). Membranes were blocked in 5% fat-free dried 
milk powder (Sigma, St. Luis, USA) in: 
 
T-TBS Buffer:  50 mM Tris 
150 mM NaCl 
0.05% Tween-20  
 
and incubated with the indicated antibodies overnight at 4°C. The blots were washed 3 
times with T-TBS and incubated for another hour with second antibodies. Blots were 
developed with SuperSignal West Pico Chemiluminescent Substrate detection kit (Thermo 
Scientific, Waltham, MA, USA), as recommended by the manufacturer. ImageJ was used 
for densitometric analysis. 
 
2.19. Membrane fractioning  
 
A549 cells in 100 mm plates were transfected with V5-β1 S11D. 18 hours later cells were 
washed three times with PBS Ca+ Mg+ and resuspended in: 
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Membrane Fractioning Buffer 1: 3 mM Imidazole (pH 7.2) 
250 mM Sucrose  
1 mM EDTA  
Protease inhibitor cocktail  
 
Cell monolayer was scraped and homogenized with a syringe. Cell debris was 
removed by 10 minutes centrifugation at 2000 rpm. Then, supernatant was ultracentrifuged 
for 1 hour at 35000 rpm (rotor T120). Membrane pellet was resuspended in:  
 
Membrane Fractioning Buffer 2: 3 mM Imidazole (pH 7.5) 
250 mM Sucrose  
1 mM EDTA 
1 mg/ml C12E10  
Protease inhibitor cocktail  
 
homogenized with a syringe and incubated during 30 minutes in the dark. Then, 
supernatant was ultracentrifuged for 1 hour at 35000 rpm (rotor T120). The supernatant 
contained membrane proteins soluble in C12E10. Samples were used in the ubiquitin protein 
microarray. 
 
2.20. Ubiquitin protein microarray 
 
The membrane fraction isolated from A549 transfected with V5-β1 S11D was used in an 
ubiquitin protein microarray (LifeSensors, Catalog # MA101). V5-β1 S11D was detected 
by the use of anti-V5 antibody conjugated with Alexa Fluor 647 (Invitrogen, Karlsruhe, 
Germany). 
 
2.21. Immunofluorescence microscopy 
 
Cells were plated on cover slips and prepared for fluorescence microscopy at day three. 
A549 cells were exposed to normocapnia or hypercapnia media for the indicated times at 
37°C in the humidified C-Chamber. Cells were washed three times with PBS Ca+ Mg+ and 
fixed by adding 3.7% formaldehyde for 4 minutes at 4°C. 
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After washing the cover slips three times they were blocked in PBS Ca+ Mg+ 
containing 2% BSA for 30 min at room temperature. Cover slips were then incubated 
overnight at 4°C in the indicated antibody in blocking solution. The next day cover slips 
were washed with PBS Ca+ Mg+ and incubated with FITC-conjugated secondary antibody. 
Cover slips were placed on glass slides with fluorescent Vectashield mounting medium 
(Vector Laboratories, Cambridgeshrie, UK). Analysis was undertaken by using a 
fluorescence microscope (Leica DMLA Q550/W; Leica Microsystems), a digital camera 
(DC 300 FX; Leica Microsystems) and software (Q-Win; Leica Microsystems).  
To study the kinetics of the movement of the Na,K-ATPase β-subunit, A549-β1-
YFP cells were incubated in normocapnia or hypercapnia β1-YFP was followed by time-
lapse microscopy under a confocal microscope (Leica SP5 inverted; Leica Microsystems).  
 
2.22. Cell aggregation assay 
 
A549 cells or rat primary ATII cells (40000 cells/drop; 4 drops/experiment) were 
incubated in presence of vehicle (DMSO) or MG-132 (20μM) or transfected with V5-β1 
wt and variants and exposed to normocapnia or hypercapnia during 4 or 8 hours (indicated 
for each experiment in Section 3), after which the whole drop was fixed with 3.7% 
formaldehyde and mounted. Pictures were taken and the number of cells per aggregate was 
determined. ImageJ was used for the analysis of the pictures. A scale was set in which the 
area corresponding to one average-size cell was call 1 unit, thus area units were equivalent 
to number of cells. 
 
2.23. Statistical analysis of data 
 
Values are expressed as mean ± standard error of the media (SEM). Comparisons between 
two groups were made using a paired, two tailed Student’s t-test. Comparisons between 
more than two groups were done using One-Way ANOVA test and Tukey multiple 
comparisons. Statistical significance was defined as *p<0.05, **p<0.005, ***p<0.0005. 
GraphPad Prism 5 for Windows software (GraphPad Software; San Diego, USA) was used 
for data plotting and statistical analysis. 
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3. Results 
 
Most of the mechanistic studies oriented to determine hypercapnia effects on Na,K-
ATPase β-subunit required the expression of Na,K-ATPase β-subunit wild type (wt) and 
mutant proteins as well as the down-regulation of specific targets via siRNA transfections. 
Since efficient lipid-mediated DNA transfection into A549 cells is possible, most of our 
experiments were conducted in this alveolar epithelial cell line, in which the function and 
expression of the Na,K-ATPase are fully characterized and similar to primary ATII cells 
[127, 128, 176, 177]. However, cell-adhesion experiments were validated in primary rat 
ATII cells, known to form mature cellular junctions and a tight and polarized monolayer 
[85, 178, 179, 185]. 
The effects of elevated CO2 on the alveolar epithelium were evaluated by exposing 
cells to 110 mmHg of CO2, which is considered to be clinically-relevant since CO2 levels 
may rise up to 100 mmHg in mechanically-ventilated ARDS patients [114, 115, 186-189] 
and up to 250 mmHg in patients with uncontrolled asthma [190, 191]. Importantly, since a 
constant extracellular pH (pHe) of 7.4 was employed in all our studies, the observed effects 
of elevated CO2 on alveolar cells were not due to hypercapnia-associated acidosis. 
Intracellular pH (pHi) was not particularly controlled in these experiments, since previous 
studies demonstrated that exposure of cells to elevated CO2 at a pHe of 7.4 led only to a 
mild and transient decrease in pHi, which rapidly returned to basal levels [127]. 
 
3.1. Elevated CO2 levels impair alveolar epithelial cell-cell junction formation 
 
During ARDS, disruption of the alveolar-capillary barrier integrity and formation of edema 
leads to impaired gas exchange. Restoration of the physical integrity of the alveolar 
epithelial monolayer is critical for the removal of liquid from the alveolar space and re-
establishment of a functional respiratory epithelium [6]. However, elevated CO2 levels due 
to impaired gas exchange could have negative effects on the mechanisms of repair of the 
alveolar epithelium. Particularly, the impact of hypercapnia on the organization of cell-cell 
contacts has not been addressed before. Therefore, to evaluate whether elevated CO2 levels 
affect the ability of epithelial cells to interact with each other we conducted a cell 
aggregation assay, also termed “hanging drop”, in which a single-cell suspension of A549 
cells was incubated in normocapnic (40 mmHg CO2, pH 7.4) or hypercapnic (110 mmHg  
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CO2, pH 7.4) conditions at normal pH for 8 hours. Data analysis showed that the number 
of large aggregates, defined as aggregates containing more than 10 cells, was significantly 
reduced in hypercapnia compared to normocapnia, suggesting that elevated CO2 levels 
were impairing the ability of cells to interact with their neighbors. Interestingly, the 
deleterious effects of hypercapnia on cell-cell contact formation were partially prevented 
when A549 cells were incubated with the proteasome inhibitor, MG-132, suggesting that 
the negative impact of elevated CO2 on cell adhesion may involve a proteasome-dependent 
event, perhaps by inducing degradation of one or more adhesion molecules (Figure 11). 
 
 
 
Figure 11: Elevated CO2 levels impair cell-cell contact formation in A549 cells. A549 cells were 
incubated in normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) in the presence 
of vehicle (DMSO) or MG-132 proteasome inhibitor for 8 hours. The number of aggregates containing more 
than 10 cells was determined. Mean ± SEM, n = 4, unpaired t-test, **p < 0.005. Scale bar = 50 µM. 
 
The above-mentioned results were confirmed in a second set of experiments conducted in 
rat primary ATII cells. Due to its highly-adhesive phenotype, primary ATII cells formed 
larger aggregates than A549 cells. However, similarly to A549 cells, the adhesive 
properties were impaired in cells exposed to hypercapnia (110 mmHg CO2, pH 7.4), thus 
demonstrating the adverse effects of elevated CO2 levels on the ability of cells to establish 
cell-cell contacts (Figure 12). 
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Figure 12: Elevated CO2 levels impair cell-cell contact formation in ATII cells. Primary rat ATII cells 
were incubated in normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) for 4 
hours. The number of aggregates containing more than 20 cells was determined. Mean ± SEM, n = 3, 
unpaired t-test, *p < 0.05. Scale bar = 50 µM. 
 
3.2. Elevated CO2 levels induce the endocytosis of the Na,K-ATPase β-subunit in 
alveolar epithelial cells 
 
Na,K-ATPase β-subunit consists of 2 N-glycosylated isoforms that are detected as a broad 
band at 45-55 kDa and a sharper band at ~40 kDa. Only the fully-glycosylated band is 
found at the plasma membrane where it participates in homophilic cell-cell adhesion [93, 
192]. To test the hypothesis that elevated CO2 levels impair alveolar cell-cell adhesion by 
affecting the localization of the Na,K-ATPase β-subunit at the cell surface, we conducted 
immunofluorescence experiments in which A549 cells were exposed to normocapnia (40 
mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) for 30 minutes and Na,K-
ATPase β-subunit localization was observed under confocal microscopy. Cells exposed to 
elevated CO2 levels showed a decrease in Na,K-ATPase β-subunit abundance at the plasma 
membrane, accompanied by a translocation of the protein into the intracellular 
compartments (Figure 13). 
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Figure 13: Elevated CO2 levels alter Na,K-ATPase β-subunit subcellular localization in A549 cells. 
A549 cells were incubated in normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 
7.4) for 30 minutes. Na,K-ATPase β-subunit was detected by the use of anti-Na,K-ATPase β1-subunit 
antibody followed by FITC-conjugated secondary antibody. Fluorescence was observed at a confocal 
microscope. Scale bar = 10 µM. 
 
To further characterize the kinetics of the movement of the Na,K-ATPase β-subunit 
in cells exposed to elevated CO2 levels, we employed time-lapse confocal microscopy. 
A549 cells stably expressing dog Na,K-ATPase β-subunit fused to yellow fluorescence 
protein (A549-β1-YFP) were incubated in normocapnia (40 mmHg CO2, pH 7.4) or 
hypercapnia (110 mmHg CO2, pH 7.4) for 12 minutes, collecting pictures every minute. 
Whereas in normocapnia, Na,K-ATPase β-subunit was located at the borders of adjacent 
cells, in hypercapnia a redistribution of Na,K-ATPase β-subunit was evident already 6 
minutes after elevated CO2 exposure. After exposing cells to hypercapnic media for 12 
minutes, most of the Na,K-ATPase β-subunit was endocytosed from the plasma membrane 
into intracellular compartments (Figure 14).  
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Figure 14: Elevated CO2 levels lead to a decrease in Na,K-ATPase β-subunit surface abundance within 
minutes. Using time-lapse confocal microscopy, we analyzed the kinetics of Na,K-ATPase β-subunit in 
A549-β1-YFP cells over 0-12 minutes of exposure to normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia 
(110 mmHg CO2, pH 7.4). Images were collected every 1 minute. Representative pictures at 0, 6 and 12 
minutes are shown here. Scale bar = 10 µM. 
 
To quantitatively evaluate the hypercapnia-induced endocytosis of the Na,K-
ATPase β-subunit , cells were exposed to normocapnia (40 mmHg CO2, pH 7.4) or 
hypercapnia (110 mmHg CO2, pH 7.4) for 30 minutes after which biotin-streptavidin pull-
downs were performed to determine Na,K-ATPase β-subunit protein levels at the plasma 
membrane. The results of these experiments showed a 30% reduction of Na,K-ATPase β-
subunit at the membrane of cells exposed to elevated CO2 levels compared to cells exposed 
to normocapnia. In contrast, total levels of the Na,K-ATPase β-subunit did not show 
significant changes after treatment with elevated CO2 concentrations (Figure 15). The 
specific detection of plasma membrane proteins, due to cell impermeability to biotin, was 
confirmed by the fact that only the ~50-kDa mature form of Na,K-ATPase β-subunit was 
detected in the pull-downs. 
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Figure 15: Elevated CO2 levels promote the endocytosis of the Na,K-ATPase β-subunit. A549 cells were 
exposed to normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) for 30 minutes. 
Na,K-ATPase β-subunit at the surface was determined by biotin-streptavidin pull-down and IB. 
Representative Western blots of Na,K-ATPase β-subunit at the surface and total protein abundance are 
shown. Mean ± SEM, n = 5, paired t-test, ****p < 0.0001. 
 
3.3. Na,K-ATPase β-subunit turnover under steady-state conditions is proteasome-
dependent 
 
Understanding the timing and mechanism of Na,K-ATPase β-subunit degradation under 
steady-state conditions was important for our future studies on Na,K-ATPase β-subunit 
stability under hypercapnic conditions. 
To determine the half-life of endogenous Na,K-ATPase β-subunit under steady-
state conditions in our system, we labeled membrane proteins with cell-impermeable 
biotin, incubated A549 cells in normal conditions (40 mmHg CO2, pH 7.4) for 4 and 6 
hours and did protein pull-downs with streptavidin. We found that after 4 hours 
approximately 50% of cell surface Na,K-ATPase β-subunit was degraded (Figure 16). 
This observation was in agreement with previous studies done by other groups in HeLa and 
A549 cells which have shown that cell surface Na,K-ATPase β-subunit has a half-life of 
approximately 4 hours in steady-state conditions [193, 194]. 
As protein degradation can be proteasome- or lysosome-mediated, we set out to 
determine the mechanism involved in the degradation of the Na,K-ATPase β-subunit under 
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steady-state conditions in the alveolar epithelium. Biotin-labeled proteins were chased in 
the presence of the proteasome inhibitor, MG-132 or the lysosome inhibitor, chloroquine. 
Normal turnover of the Na,K-ATPase β-subunit was prevented in the presence of the 
proteasome inhibitor but not when the lysosomal function was inhibited (Figure 16). 
These studies suggest that degradation of the Na,K-ATPase β-subunit located at the plasma 
membrane is primarily mediated by the proteasome system under steady state conditions. 
These findings are in line with published data in which inhibition of the proteasome system 
prevented Na,K-ATPase β-subunit degradation under steady-state conditions in HeLa cells 
[193]. 
      
 
Figure 16: Plasma membrane Na,K-ATPase β-subunit has a half-life of 4 hours and its turnover 
requires the proteasome function. Surface proteins of A549 cells were labeled with biotin and chased in 
normocapniaconditions (40 mmHg CO2, pH 7.4) for 4 and 6 hours in the presence of vehicle (DMSO), 
proteasome inhibitor (MG-132, MG) or lysosome inhibitor (chloroquine, Chlor) . Afterwards, streptavidin 
pull-down was performed and Na,K-ATPase β-subunit abundance was analyzed by IB. Representative 
Western blot of Na,K-ATPase β-subunit protein abundance is shown. 
 
Although our studies mainly focused on the plasma membrane Na,K-ATPase β-
subunit, to further characterize Na,K-ATPase β-subunit degradation mechanism under 
steady state conditions, we set out to examine Na,K-ATPase β-subunit degradation, not 
only at the plasma membrane but in total cell lysates. It has been previously reported that 
isoforms of the Na,K-ATPase β-subunit are degraded differently in MDCK cells, the 
immature Na,K-ATPase β-subunit being degraded faster than the mature isoform, levels of 
which decreased only slightly after 5 hours [192]. However, the mechanism of degradation 
of the different isoforms has not been addressed in these studies. 
To assess the mechanism of Na,K-ATPase β-subunit degradation in total cell 
lysates under steady-state conditions, A549 cells were incubated in the presence of the 
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protein-synthesis inhibitor, cycloheximide (CHX). Indeed, these studies showed that 
immature Na,K-ATPase β-subunit is degraded faster than total mature Na,K-ATPase β-
subunit in A549 cells. After 4 hours incubation with CHX, approximately 50% of 
immature Na,K-ATPase β-subunit was degraded, whereas no significant changes were 
observed in the amount of total mature Na,K-ATPase β-subunit (Figure 17). 
 
 
 
Figure 17: Endoplasmic reticulum Na,K-ATPase β-subunit has higher turnover than mature β-subunit 
and the proteasome pathway is involved. A549 cells were incubated with the protein synthesis inhibitor, 
cycloheximide (CHX), for 4 hours in the presence of vehicle (DMSO), proteasome inhibitor (MG-132, MG) 
or lysosome inhibitor (chloroquine, Chlor) in normal (40 mmHg CO2, pH 7.4) conditions. Afterwards, Na,K-
ATPase β-subunit abundance in total cell lysates was analyzed by IB. Representative Western blot shows 
mature Na,K-ATPase β1-subunit, endoplasmic reticulum-associated Na,K-ATPase β1-subunit (ER) and 
deglycosylated Na,K-ATPase β1-subunit. Mean ± SEM, n = 3, paired t-test, *p < 0.05, **p<0.005. 
 
It has been previously described that some glycoproteins may be retro-translocated 
from the endoplasmic reticulum into the cytosol, subsequently deglycosylated and 
degraded via the proteasomal pathway [195, 196]. However, it remained unknown whether 
the intracellular immature Na,K-ATPase β-subunit form undergoes this pathway. 
Importantly, in our experiments we observed that proteasome inhibition with MG-132, but 
not lysosome inhibition, led to the accumulation of a ~35 kDa form of the Na,K-ATPase β-
subunit (Figure 17), which comigrated with PNGaseF-degycosylated Na,K-ATPase β-
subunit forms in SDS-PAGE (data not shown). This result suggests that immature Na,K-
ATPase β-subunit gets deglycosylated before being degraded and that, similarly to plasma 
membrane Na,K-ATPase β-subunit, immature Na,K-ATPase β-subunit is also degraded by 
the proteasome.  
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Taken together, these results strongly imply that the Na,K-ATPase β-subunit is 
degraded by the proteasome irrespective of its location or maturations status.  
 
3.4. Elevated CO2 levels promote the degradation of the plasma membrane Na,K-
ATPase β-subunit 
 
In the previous experiments we demonstrated that elevated CO2 levels induced Na,K-
ATPase β-subunit internalization from the plasma membrane. Since internalized proteins 
may be recycled or degraded, we set out to study whether hypercapnia-induced 
endocytosis of the Na,K-ATPase β-subunit was followed by its degradation. To this end, 
we conducted pulse-chase experiments with cell-impermeable biotin in normocapnia (40 
mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4). After 1 hour of exposure to 
hypercapnia, 44% of the Na,K-ATPase β-subunit was degraded, as opposed to a markedly 
slower degradation rate under normocapnia (Figure 18).  
 
 
 
Figure 18: Elevated CO2 levels promote the degradation of the plasma membrane Na,K-ATPase β-
subunit.  Surface proteins of A549 cells were labeled with biotin and chased in normocapnia (40 mmHg 
CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) for 1 hour. Afterwards, streptavidin pull-down was 
performed and Na,K-ATPase β-subunit abundance was analyzed by IB. Representative Western blot of 
surface Na,K-ATPase β-subunit total protein abundance is shown. Mean ± SEM, n = 3, paired t-test, 
*p<0.05. 
 
In a second set of experiments, we transfected A549 cells with a C-terminal V5-
tagged Na,K-ATPase β-subunit wild-type (V5-β1 wt) construct and performed pulse-chase 
experiments with cell-impermeable biotin in normocapnia (40 mmHg CO2, pH 7.4) or  
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hypercapnia (110 mmHg CO2, pH 7.4) for different time points. These studies clearly 
showed that hypercapnia promoted the fast degradation of plasma membrane V5-β1 wt, 
having a strong impact on the protein half-life which was reduced to 1 hour.  
In summary, our data show that elevated CO2 levels lead to the endocytosis and 
degradation of the plasma membrane Na,K-ATPase β-subunit (Figure 19). 
 
 
 
Figure 19: Elevated CO2 levels promote the rapid degradation of the plasma membrane V5-β1 wt. 
A549 cells were transfected with V5-β1 wt and surface proteins were labeled with biotin and chased in 
normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) for different time points. 
Afterwards, streptavidin pull-down was performed and Na,K-ATPase β-subunit abundance was analyzed by 
IB. Representative Western blot of surface Na,K-ATPase β-subunit total protein abundance is shown. Mean 
± SEM, n = 3, paired t-test, *p<0.05.  
 
3.5. Hypercapnia-induced Na,K-ATPase β-subunit degradation is mediated by the 
 proteasome 
 
To elucidate the pathway implicated in hypercapnia-induced endocytosis and degradation 
of the Na,K-ATPase β-subunit, we assessed plasma membrane Na,K-ATPase β-subunit 
protein abundance in A549 cells exposed to high CO2 in the presence of inhibitors of the 
lysosome, chloroquine and E64, and of the proteasome, MG-132. Exposure of cells to 
hypercapnia in the absence of inhibitors decreased the plasma membrane Na,K-ATPase β-
subunit protein abundance by approximately 25%. This effect was completely prevented 
by pretreatment of cells with the proteasome inhibitor. In contrast, pretreatment of cells 
with lysosome inhibitors did not prevent the hypercapnia-induced effect on the plasma 
membrane of the Na,K-ATPase β-subunit (Figure 20). 
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Figure 20: Inhibition of the proteasome prevents CO2-induced Na,K-ATPase β-subunit endocytosis. 
A549 cells were preincubated with vehicle (DMSO), proteasome inhibitor (MG-132) or lysosome inhibitors 
(chloroquine, Chlor, and E64) for 4 hours and then exposed to normocapnia (40 mmHg CO2, pH 7.4) or 
hypercapnia (110 mmHg CO2, pH 7.4) for 30 minutes. Biotin-streptavidin pull-down of cell surface proteins 
was performed and Na,K-ATPase β-subunit abundance  was analyzed by IB. Representative Western blots of 
surface Na,K-ATPase β-subunit abundance are shown. Mean ± SEM, n = 3, paired t-test, *p<0.05.  
 
In a second set of experiments, we further examined hypercapnia-mediated 
pathway of Na,K-ATPase β-subunit degradation by conducting pulse-chase experiments 
with impermeable-biotin in the presence of lysosome and proteasome inhibitors. Exposure 
of cells to elevated CO2 levels in the presence of lysosome inhibitor increased degradation 
of the plasma membrane Na,K-ATPase β-subunit protein by approximately 35% compared 
to control cells, whereas the same experiment in the presence of the proteasome inhibitor, 
MG-132 did not significantly increased plasma membrane Na,K-ATPase β-subunit protein 
degradation (Figure 21). 
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Altogether, these studies suggest that the hypercapnia-induced degradation of the 
Na,K-ATPase β-subunit located at the plasma membrane involves a proteasome-mediated 
event. 
  
 
 
Figure 21: Inhibition of the proteasome prevents CO2-induced Na,K-ATPase β-subunit degradation. 
A549 cells were preincubated with vehicle (DMSO), proteasome inhibitor (MG-132) or lysosomal inhibitor 
(chloroquine) for 4 hours. Surface proteins of A549 cells were labeled with biotin and chased in normocapnia 
(40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) for 1 hour. Afterwards, streptavidin pull-
down was performed and Na,K-ATPase β-subunit abundance  was analyzed by IB. Representative Western 
blots of surface Na,K-ATPase β-subunit abundance are shown. Mean ± SEM, n = 3, paired t-test, *p<0.05.  
 
3.6. Hypercapnia induces the ubiquitination of the Na,K-ATPase β-subunit at the 
plasma membrane 
 
In the last decades, the endocytosis of multiple classes of proteins has been found to be 
regulated by the ubiquitin system [129, 197]. Therefore, the next step was to evaluate 
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whether ubiquitination played a role in the hypercapnia-induced endocytosis of the Na,K-
ATPase β-subunit .  
First, we evaluated whether hypercapnia induces ubiquitination of the Na,K-
ATPase β-subunit. To this end, we transfected A549 cells with HA-ubiquitin and V5-β1 wt 
and exposed the cells to normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg 
CO2, pH 7.4). V5-β1 wt subunit was immunoprecipitated and ubiquitinated Na,K-ATPase 
β-subunit isoforms were detected with anti-HA antibody. Exposure of cells to hypercapnia 
for 15 minutes led to the ubiquitination of Na,K-ATPase β-subunit, detected as a typical 
smeared pattern over 50 kDa characteristic of polyubiquitinated proteins, due to the 
presence of polyubiquitin chains of various lengths (Figure 22).  
                             
                         
 
Figure 22: Elevated CO2 levels promote ubiquitination of the Na,K-ATPase β-subunit. A549 cells were 
cotransfected with HA-Ubiquitin (Ha-Ub) and V5- β1 wt. After 18 hours transfection, cells were exposed to 
normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) for 15 minutes in the 
presence of MG-132. V5-β1 wt was immunoprecipitated with anti-V5 polyclonal rabbit antibody and 
ubiquitinated forms were detected with anti-HA monoclonal mouse antibody by IB. Loading was done with 
anti-V5 monoclonal mouse antibody. Representative Western blots are shown.  
 
Furthermore, an increase in ubiquitination of Na,K-ATPase β-subunit after cell-
treatment with elevated CO2 could also be detected in total protein lysates when blotting 
against V5 (Figure 23). This is an alternative accepted method to detect ubiquitinated 
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proteins [198]; however it may require overexposure of x-ray films because ubiquitinated 
proteins often represent a small fraction of the total pool of a protein.  
                                    
 
Figure 23: Elevated CO2 levels promote ubiquitination of the Na,K-ATPase β-subunit. A549 cells were 
cotransfected with HA-Ubiquitin (Ha-Ub) and V5-β1 wt. After 18 hours transfection, cells were exposed to 
normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) for 15 minutes. V5-β1 wt 
was detected with anti-V5 monoclonal mouse antibody by IB. Films were overexposed to detect Na,K-
ATPase β-subunit polyubiquitinated isoforms. Total proteins with HA-ubiquitin modifications were detected 
with anti-HA antibody. Representative Western blots are shown. 
 
These experiments confirmed that elevated CO2 levels indeed triggered Na,K-
ATPase β-subunit polyubiquitination. We hypothesized that if the hypercapnia-induced  
ubiquitination of the Na,K-ATPase β-subunit plays a role in the endocytosis signaling, the 
most likely site of ubiquitination is at the plasma membrane. To test this hypothesis, we 
assessed the levels of ubiquitinated Na,K-ATPase β-subunit isoforms at the plasma 
membrane of A549 cells exposed to normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia 
(110 mmHg CO2, pH 7.4) for 15 minutes. Membrane proteins were labeled with cell-
impermeable biotin and streptavidin pull-downs were performed in order to isolate surface 
proteins. Immunoprecipatation of Na,K-ATPase β-subunit from the pool of membrane 
proteins was done to detect ubiquitinated β-subunit isoforms. A specific antibody against 
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ubiquitin was used to detect the endogenous ubiquitinated Na,K-ATPase β-subunit 
isoforms. The experiments showed a significant increase in ubiquitinated forms in cells 
exposed to elevated CO2 levels compared to cells exposed to normal CO2 levels, 
suggesting that hypercapnia promotes ubiquitination of Na,K-ATPase β-subunit at the 
plasma membrane (Figure 24). 
 
                  
 
Figure 24: Elevated CO2 levels promote ubiquitination of the Na,K-ATPase β-subunit at the plasma 
membrane. A549 cells were incubated in normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg 
CO2, pH 7.4) for 15 minutes. Biotin-streptavidin pull-down was performed to enrich in surface proteins. 
Na,K-ATPase β-subunit was immunoprecipitated with anti-β1-subunit mouse monoclonal antibody and 
Na,K-ATPase β-subunit polyubiquitinated isoforms were detected with anti-ubiquitin mouse monoclonal 
antibody by IB. Representative Western blots are shown. 
 
3.7. Hypercapnia-induced endocytosis of the Na,K-ATPase β-subunit requires 
ubiquitination of the protein at lysine residues 5 and 7 
 
Previous observations suggested that the hypercapnia-induced ubiquitination of the Na,K-
ATPase β-subunit at the plasma membrane may act as a trafficking signal responsible for 
Na,K-ATPase β-subunit endocytosis. To identify the specific lysine residues in Na,K-
ATPase β-subunit that serve as ubiquitin acceptors, we used site-directed mutagenesis to 
introduce lysine to arginine substitutions at each intracellular lysine in the intracellular 
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domain of V5-β1 wt. This is a widely-used method to identify the ubiquitination site as this 
conservative substitution preserves the positive charge and does not significantly alter the 
protein conformation [131, 199]. Moreover; considering the possibility of functional 
redundancy, mutants containing simultaneous replacements were produced.  
To perform the analysis, A549 cells were transfected with the different mutants. 
After exposure of cells to hypercapnia (110 mmHg CO2, pH 7.4) for 15 minutes, V5-β1 wt 
or mutants were immunoprecipitated and ubiquitinated Na,K-ATPase β-subunit isoforms 
were detected. Replacement of both lysines 5 and 7 with arginines (V5-β1 K5/7R), led to a 
significant prevention of hypercapnia-induced Na,K-ATPase β-subunit ubiquitination 
(Figure 25).  
 
               
 
Figure 25: Replacement of both lysines 5 and 7 with arginines prevent the hypercapnia–induced 
ubiquitination of the Na,K-ATPase β-subunit. A549 cells were transfected with V5-β1 wt, V5-β1 K5/7R 
or empty plasmid. After 18 hours transfection, cells were exposed to hypercapnia (110 mmHg CO2, pH 7.4) 
for 15 minutes. V5-β1 wt or K5/7R were immunoprecipitated with anti-V5 polyclonal rabbit antibody and 
ubiquitinated forms were detected with anti-ubiquitin monoclonal mouse antibody by IB. As loading control 
V5-β1 wt or K5/7R were detected with anti-V5 mouse antibody. Representative Western blots are shown. 
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To address the role of ubiquitination in the internalization of the Na,K-ATPase β-
subunit , we set out to examine the effect of elevated CO2 on the endocytosis of the V5-β1 
K5/7R mutant protein. A549 cells were transfected with V5-β1 wt or K5/7R contructs, 
exposed to normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 
7.4) for 30 minutes and biotin-streptavidin pull-downs were performed. Importantly, when 
lysines 5 and 7 were replaced with arginine the hypercapnia-induced endocytosis of the 
Na,K-ATPase β-subunit was prevented. These findings provide strong evidence that 
ubiquitin may function as an endocytosis signal that mediates the hypercapnia-induced 
Na,K-ATPase β-subunit endocytosis (Figure 26).  
 
 
 
Figure 26: Replacement of lysines 5 and 7 with arginines prevents the hypercapnia–induced 
endocytosis of the Na,K-ATPase β-subunit. A549 cells were transfected with V5-β1 wt or V5-β1 K5/7R. 
After 18 hours transfection, cells were exposed to normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 
mmHg CO2, pH 7.4) for 30 minutes. Afterwards, biotin-streptavidin pull-downs were performed and V5-β1 
wt or V5-β1 K5/7R abundance was analyzed by IB. Representative Western blots are shown. Mean ± SEM,  
n = 3, paired t-test, *p<0.05. 
 
In contrast, the substitution of other intracellular lysine residues of the Na,K-
ATPase β-subunit (mutants K13/14R and K21/22R) did not prevent hypercapnia-induced 
endocytosis (Figure 27). 
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Figure 27: Only replacement of lysines 5 and 7 with arginines prevents hypercapnia–induced Na,K-
ATPase β-subunit endocytosis. A549 cells were transfected with V5-β1 wt, V5-β1 K5/7R, V5-β1 K13/14R 
or V5- β1 K21/22R. After 18 hours transfection, cells were exposed to normocapnia (40 mmHg CO2, pH 7.4) 
or hypercapnia (110 mmHg CO2, pH 7.4) for 30 minutes. Afterwards, biotin-streptavidin pull-downs were 
performed and V5-β1 abundance was analyzed by IB. Representative Western blots are shown. 
 
The above-mentioned observations demonstrated that only lysines 5 and 7 act as 
ubiquitin acceptors in hypercapnia-induced Na,K-ATPase β-subunit ubiquitination and is 
required as a signal for the endocytosis of the protein.  
 
3.8. Mutations in lysine residues 5 and 7 restore hypercapnia-impaired cell-cell 
junction formation  
 
To determine whether there is a causal link between CO2-mediated effects on plasma 
membrane Na,K-ATPase β-subunit stability and cell-cell adhesion, we expressed V5-β1 
K5/7R mutant which remains at the cell surface under hypercapnic conditions, and look for 
its capacity to restore cell-cell junctions formation in cells exposed to elevated CO2 levels. 
For that, we conducted cell aggregation assays in A549 cells transfected with V5-β1 wt or 
K5/7R mutant. Importantly, since we found that cell adhesion was affected by lipid-
mediated transfection procedures, we employed nuclofection, as an alternative method to 
express V5-β1 constructs. Results from these experiments showed that whereas 
hypercapnia inhibited the formation of larger aggregates in cells expressing V5-β1 wt, this 
phenotype was prevented in cells expressing V5-β1 K5/7R, in which no differences in the 
aggregate sizes were found between normocapniaand CO2 treated cells (Figure 28).  
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Figure 28: Replacement of lysines 5 and 7 with arginines prevents hypercapnia-mediated inhibition of 
cell-cell contact formation in A549 cells. A549 nucleofected with V5-β1 wt or V5-β1 K5/7R  were 
incubated in normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) for 4 hours. 
The number of aggregates containing more than 20 cells was determined. Mean ± SEM, n = 3, unpaired t-
test, ***p<0.0005. Scale bar = 50 µM. 
 
The above-mentioned results were confirmed in a second set of experiments conducted in 
rat primary ATII cells transfected with V5-β1 wt or K5/7R mutant. It is well-known that 
primary ATII cells do not uptake DNA efficiently by lipid-mediated procedures. However, 
our group have recently demonstrated that ATII nucleofection results in highly-efficient 
DNA delivery into the cells [200], and we employed this method to express V5-β1 
constructs in this cell type. Similarly to A549 cells, cell junctions formation was impaired 
in cells exposed to hypercapnia (110 mmHg CO2, pH 7.4), thus demonstrating the 
deleterious effects of elevated CO2 levels on the ability of cells to establish cell-cell 
contacts (Figure 29). 
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Figure 29: Replacement of lysines 5 and 7 with arginines prevents hypercapnia-mediated inhibition of 
cell-cell contact formation in rat primary ATII cells. Rat primary ATII cells nucleofected with V5-β1 wt 
or V5-β1 K5/7R were incubated in normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, 
pH 7.4) for 4 hours. The number of aggregates containing more than 20 cells was determined. Mean ± SEM, 
n = 3, unpaired t-test, *p<0.05. Scale bar = 10 µM. 
 
3.9. Hypercapnia-induced ubiquitination and degradation of the Na,K-ATPase β-
subunit requires its serine 11. 
 
Protein phosphorylation at amino acid residues which are in near proximity to the sites of 
ubiquitination often serves as a phosphodegron which is recognized by the E3 ubiquitin 
ligase that mediates the ubiquitination reaction [151, 152][131, 201]. We set to evaluate if 
this was the case for Na,K-ATPase β-subunit, and based on proximity, the serine 11 
residue of the Na,K-ATPase β-subunit was a probable candidate.   
A widely-used method to identify potential phosphorylation sites consists of the 
substitution of phosphoacceptor residues to alanine, which prevents the covalent 
attachment of a phosphate group to the protein; or to aspartate or glutamate, which on the 
other hand, by adding a negative charge to the protein mimics phosphorylation [202]. 
Therefore, we used site-directed mutagenesis to introduce serine to alanine and serine to 
aspartate substitutions in the intracellular domain of V5-β1 wt (mutants S11A and S11D, 
respectively). A549 cells transfected with V5-β1 constructs were exposed to normocapnia 
(40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) for 30 minutes and 
Na,K-ATPase β-subunit ubiquitinated isoforms were detected. Serine 11 to alanine 
substitution led to a significant prevention of hypercapnia-induced Na,K-ATPase β-subunit 
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ubiquitination whereas serine 11 to aspartate substitution did not it, suggesting that 
hypercapnia-mediated ubiquitination probably requires Na,K-ATPase β-subunit 
phosphorylation at serine 11 (Figure 30).  
 
                                          
 
Figure 30: Replacement of serine 11 with alanine prevents hypercapnia-induced ubiquitination. A549 
cells were transfected with V5-β1 S11A or V5-β1 S11D. After 18 hours transfection, cells were exposed to 
hypercapnia (110 mmHg CO2, pH 7.4) for 15 minutes. V5-β1 S11A or V5-β1 S11D were 
immunoprecipitated with anti-V5 polyclonal rabbit antibody and ubiquitinated forms were detected with anti-
ubiquitin monoclonal mouse antibody by IB. Representative Western blots are shown. 
 
Based on our previous results, we hypothesized that prevention of ubiquitination of 
the Na,K-ATPase β-subunit by mutating its serine 11 residue to alanine may block the 
hypercapnia-induced endocytosis and degradation of the protein. Thus, we evaluated the 
effect of S11A and S11D mutations on hypercapnia-induced degradation. To this end, we 
conducted pulse-chase experiments with impermeable biotin in A549 cells were 
transfected with V5-β1 constructs. As anticipated, hypercapnia-induced Na,K-ATPase β-
subunit degradation was prevented in the S11A mutant but not in the S11D mutant (Figure 
31). 
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Figure 31: Replacement of serine 11 with alanine prevents hypercapnia-induced degradation of the 
Na,K-ATPase β-subunit. A549 cells were transfected with V5- β1 wt, V5- β1 S11A or V5- β1 S11D. After 
18 hours transfection, surface proteins were labeled with cell-impermeable biotin and chase in normocapnia 
(40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) for 1 hour. Afterwards, streptavidin pull-
down was performed and Na,K-ATPase β-subunit abundance was analyzed by IB. Representative Western 
blots are shown. Mean ± SEM, n = 3, paired t-test, *p<0.05. 
 
Mutations of the other intracellular serine residues did not affect hypercapnia-
induced effects on the Na,K-ATPase β-subunit (data not shown).   
 
Taken together, these experiments prove that the hypercapnia-induced 
ubiquitination and subsequent degradation of the Na,K-ATPase β-subunit requires the 
serine 11 residue of the protein. Though not directly addressed in these experiments, it is 
reasonable to speculate that probably hypercapnia induces Na,K-ATPase β-subunit serine 
11 phosphorylation, which is probably required as a docking site for the ubiquitination 
machinery. Additional evidence supporting this notion, is the fact that when serine 11 is 
mutated to aspartate, which adds a negative charge and mimics phosphorylation, the 
hypercapnia-induced endocytosis and degradation of the Na,K-ATPase β-subunit are not 
prevented. The fact that this phosphomimic mutant alone is not sufficient to replicate the 
hypercapnia-induced effects on the Na,K-ATPase β-subunit suggests that other stimuli, 
apart from phosphorylation, are required.  
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3.10. Hypercapnia induces the interaction of PKC-ζ with the serine 11 of the Na,K-
ATPase β-subunit  
 
Our above-mentioned data suggest that elevated CO2 levels may lead to activation of a 
kinase that specifically recognizes, binds and phosphorylates the Na,K-ATPase β-subunit 
at serine 11. Previous studies from our group conducted in alveolar epithelial cells, have 
provided strong evidence that protein kinase C ζ (PKC-ζ) becomes activated in response to 
elevated CO2 levels and translocates from the cytosol to the plasma membrane where it 
adds phosphate groups to specific membrane targets [127, 128].  
 If Na,K-ATPase β-subunit is a substrate of PKC-ζ, it is expected that the proteins 
interact with each other. To test this hypothesis, A549 cells stably expressing the Na,K-
ATPase β-subunit fused to an N-terminal YFP tag (A549-β1-YFP).were used in 
coimmunoprecipitation studies. Since the YFP tag adds 35 kDa to Na,K-ATPase β-subunit, 
β1-YFP protein does not comigrate with the immunoprecipitating IgG heavy chain, as 
opposed to endogenous Na,K-ATPase β-subunit. Cells were exposed to normocapnia (40 
mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) for 10 minutes and β1-YFP 
protein was immunoprecipitated from total protein lysates. These experiments revealed 
that PKC-ζ coimmunoprecipitated with Na,K-ATPase β-subunit in both normocapnica and 
hypercapnic conditions (Figure 32).  
  
                            
 
Figure 32: PKC-ζ interacts with Na,K-ATPase β-subunit in A549 cells. A549-β1-YFP cells were exposed 
to normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) for 10 minutes. β1-YFP 
protein was immunoprecipitated from total lysates with anti-GFP monoclonal mouse antibody and PKC-ζ 
was detected with anti-PKC-ζ monoclonal mouse antibody by IB. Representative Western blot is shown.  
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To confirm the binding of PKC-ζ to Na,K-ATPase β-subunit, in vitro experiments 
were conducted, for which we designed synthetic peptides containing the entire  
intracellular domain of the Na,K-ATPase β-subunit (cyt-β1 wt peptide) where we expected 
PKC-ζ to bind (Figure 33). Protein extracts from A549 cells exposed to normocapnia (40 
mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) for 10 minutes were 
incubated with biotinylated cyt-β1 wt peptide, followed by streptavidin pull-downs. These 
experiments showed that PKC-ζ was bound to the intracellular portion of Na,K-ATPase β-
subunit and revealed that elevated CO2 levels led to an increase in PKC-ζ interaction with 
the Na,K-ATPase β-subunit (Figure 33). 
 
 
 
Figure 33: PKC-ζ interacts with Na,K-ATPase β-subunit intracellular domain in vitro. A549 cells were 
exposed to normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) for 10 minutes. 
Total lysates were incubated with biotinylated synthetic peptides containing the whole β-subunit intracellular 
domain (cyt-β1 wt peptide) overnight and streptavidin pull-downs were performed. PKC-ζ was detected with 
anti-PKC-ζ monoclonal mouse antibody by IB. Representative Western blots are shown. Mean ± SEM, n = 3, 
paired t-test, *p<0.05. 
 
To further verify the phosphorylation site in Na,K-ATPase β-subunit, we designed 
peptides containing mutations for each intracellular serine. We reasoned that once Na,K-
ATPase β-subunit is phosphorylated by PKC-ζ, the affinity of the kinase to the Na,K-
ATPase may decrease. Therefore, we mutated each serine residue of the Na,K-ATPase β-
subunit to aspartate to mimic phosphorylation, and identified which mutation affected 
PKC-ζ interaction with β-subunit. In line with our previous findings, only when serine 11 
was mutated to aspartate, PKC-ζ binding to Na,K-ATPase β-subunit was prevented 
(Figure 34). 
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Figure 34: Only the mutation of serine 11 to aspartate prevents PKC-ζ interaction with β-subunit 
intracellular domain. A549 cells were exposed to normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia 
(110 mmHg CO2, pH 7.4) for 10 minutes. Total lysates were incubated with biotinylated synthetic peptides 
containing the whole Na,K-ATPase β-subunit intracellular domain wt or mutated (cyt-β1 peptide wt, S11D, 
S19D, S31D) overnight and streptavidin pull-downs were performed. PKC-ζ was detected with anti-PKC-ζ 
monoclonal mouse antibody by IB. Representative Western blots are shown. Mean ± SEM, n = 3, one-way 
ANOVA and Tukey´s multiple comparisons, ***p<0.0005 vs β1-wt. 
 
Altogether, these experiments provided strong evidence of the interaction between 
PKC-ζ and Na,K-ATPase β-subunit, in which the serine 11 residue of the Na,K-ATPase is 
involved. Moreover, our data suggest that elevated CO2 levels might facilitate this 
interaction, which is expected given that hypercapnia activates PKC-ζ [128].  
 
3.11. Hypercapnia-induced endocytosis of the Na,K-ATPase β-subunit requires the 
activity of PKC-ζ 
 
To determine whether the activity of PKC-ζ was required for the hypercapnia-induced 
endocytosis of the Na,K-ATPase β-subunit, we assessed plasma membrane Na,K-ATPase 
β-subunit protein abundance in A549 cells exposed to elevated CO2 in the presence of PKC 
inhibitor bisindolmaleimide I (Bis). These experiments showed that inhibition of PKC 
activity prevented hypercapnia-induced endocytosis of Na,K-ATPase β-subunit (Figure 
35). 
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Figure 35: Inhibition of PKC activity prevents hypercapnia-induced endocytosis of the Na,K-ATPase 
β-subunit. A549 cells were pre-incubated with vehicle (DMSO) or PKC inhibitor (bisindolmaleimide I, Bis) 
for 30 minutes and exposed to normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 
7.4) for 30 minutes. Biotin-streptavidin pull-down of cell surface proteins was performed and analyzed by IB. 
Representative Western blots are shown. Mean ± SEM, n = 3, paired t-test, *p<0.05. 
 
Considering that Bis inhibits the activity of several members of the PKC family, we 
further examined the requirement of PKC-ζ in the hypercapnia-induced effects on β-
subunit endocytosis by knocking down PKC-ζ expression with the use of a specific siRNA. 
A549 cells transfected with siRNA against PKC-ζ or a scrambled siRNA as a control, were 
exposed to normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 
7.4) for 30 minutes and plasma membrane Na,K-ATPase β-subunit abundance was 
determined by biotin-streptavidin pull-downs. These experiments showed that when PKC-ζ 
expression was significantly downregulated, hypercapnia-induced β-subunit endocytosis 
was completely prevented (Figure 36). 
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Figure 36: Knock-down of PKC-ζ by siRNA prevents hypercapnia-induced endocytosis of the Na,K-
ATPase β-subunit.  A549 cells were transfected with siRNA against PKC-ζ or scramble siRNA. After 72 
hours transfection, cells were exposed to normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg 
CO2, pH 7.4) for 30 minutes. Biotin-streptavidin pull-down of cell surface proteins was performed and Na,K-
ATPase β-subunit abundance was analyzed by IB. Representative Western blots are shown. Mean ± SEM,    
n = 3, paired t-test, *p<0.05. 
 
These results provide strong evidence that PKC-ζ activity is required for the 
hypercapnia-induced ubiquitination and endocytosis of Na,K-ATPase β-subunit.  
 
3.12. TRAF2 E3 ligase interacts with the Na,K-ATPase β-subunit 
 
So far our data support the hypothesis that elevated CO2 levels lead to Na,K-ATPase β-
subunit polyubiquitination at lysines 5 and 7, which act as a signal for the endocytosis of 
the protein. In the ubiquitination process, the substrate specificity is conferred by the E3 
ubiquitin ligases [136]. Therefore, we set out to identify the E3 ligase involved in the 
hypercapnia-induced Na,K-ATPase β-subunit ubiquitination. To this end, we used a 
protein microarray to screen for proteins that interact with human Na,K-ATPase β-subunit. 
Based on our previous results suggesting that the phosphorylation of Na,K-ATPase β-
subunit at serine 11 might be required for hypercapnia-induced ubiquitination, a protein 
lysate from cells expressing Na,K-ATPase β-subunit phosphomimic (V5-β1 S11D) was 
applied to a microarray of more than 9000 human proteins, among which 239 were 
ubiquitin E3 ligases. After a hypothesis-driven analysis of the 47 E3 ligases that were 
found to significantly interact with Na,K-ATPase β-subunit in vitro, we identified tumor 
necrosis factor (TNF) receptor-associated factor 2 (TRAF2) as a likely candidate. 
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It has been recently described that TRAF2 can act as a RING E3 ubiquitin ligase 
when bound to intracellularly-produced sphingosine-1-phosphate (S1P), which acts as a 
cofactor of the enzyme [198].  
We first set out to confirm the interaction of TRAF2 with Na,K-ATPase β-subunit 
by performing coimmunoprecipitation experiments. Na,K-ATPase β-subunit was 
immunoprecipitated from protein lysates of A549 cells exposed to normocapnia (40 mmHg 
CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) for 10 minutes. TRAF2 
coimmunoprecipited with Na,K-ATPase β-subunit in both normocapnic and hypercapnic 
conditions, indicating that indeed TRAF2 is interacting with Na,K-ATPase β-subunit. 
Importantly, we were also able to detect PKC-ζ in these coimmunoprecipitation studies 
(Figure 37).  
 
 
 
Figure 37: TRAF2 interacts with the Na,K-ATPase β-subunit in A549 cells. A549 were exposed to 
normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) for 10 minutes. Na,K-
ATPase β-subunit was immunoprecipitated from total lysates with anti-Na,K-ATPase β1-subunit monoclonal 
mouse antibody and TRAF2 and PKC-ζ were detected with their respective antibodies by IB. Representative 
Western blots are shown.  
 
We were able to further confirm the binding of TRAF2 to Na,K-ATPase β-subunit 
by performing a reverse coimmunoprecipitation in which we immunprecipitated TRAF2 
and detected Na,K-ATPase β-subunit (Figure 38). 
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Figure 38: TRAF2 interacts with the Na,K-ATPase β-subunit in A549 cells. A549 were exposed to 
normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) for 10 minutes. TRAF2 was 
immunoprecipitated from total lysates with anti-TRAF2 polyclonal rabbit antibody and Na,K-ATPase β-
subunit was detected anti-Na,K-ATPase β1-subunit antibody by IB. Representative Western blots are shown. 
 
To further validate TRAF2 interaction with Na,K-ATPase β-subunit we conducted 
in vitro experiments, for which total lysates from A549 cells exposed to normocapnia (40 
mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) for 10 minutes were 
incubated with biotinylated cyt-β1 wt peptides. In line with our previous results, we 
detected TRAF2 in the streptavidin pull-downs, confirming that TRAF2 binds to the 
intracellular domain of Na,K-ATPase β-subunit (Figure 39). 
 
               
 
Figure 39: TRAF2 interacts with the intracellular domain of the Na,K-ATPase β-subunit in vitro. A549 
cells were exposed to normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg CO2, pH 7.4) for 10 
minutes. Total lysates were incubated with biotinylated cyt-β1 wt peptide overnight and streptavidin pull-
downs were performed. TRAF2 was detected with anti-TRAF2 monoclonal mouse antibody by IB. 
Representative Western blots are shown. 
 
3.13. TRAF2 ubiquitinates the Na,K-ATPase β-subunit  
 
We also conducted experiments to assess the potential effect of TRAF2 overexpression on 
the ubiquitination of the Na,K-ATPase β-subunit. For that, we transfected A549 cells with 
a TRAF2-GST construct, and detected Na,K-ATPase β-subunit ubiquitinated forms in the 
total lysates by overexposing films. TRAF2 overexpression caused a substantial 
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accumulation of the ubiquitinated Na,K-ATPase β-subunit isoforms, as opposed to 
untransfected cells (Figure 40). 
 
 
Figure 40: TRAF2 overexpression increases the ubiquitination of the Na,K-ATPase β-subunit. 
Ubiquitinated Na,K-ATPase β-subunit isoforms were detected in total lysates from A549 cells transfected 
with TRAF2-GST construct or untransfected, by anti Na,K-ATPase β-subunit antibodies. Overexposition of 
the films shows Na,K-ATPase β-subunit polyubiquitinated isoforms. Representative Western blots are 
shown. 
 
To evaluate whether TRAF2 directly mediates Na,K-ATPase β-subunit 
ubiquitination, we conducted in vitro ubiquitination experiments, in which 
immunoprecipitated TRAF2 supplemented with its cofactor, S1P, were employed as a 
source of E3 ubiquitin ligase to ubiquitinate the cyt-β1 wt peptide. Following the 
ubiquitination reaction, biotinylated cyt-β1 wt peptides were isolated with streptavidin 
pull-downs and the ubiquitinated Na,K-ATPase β-subunit isoforms were detected with 
anti-ubiquitin antibodies. In these studies, we observed a significant accumulation of 
ubiquitinated Na,K-ATPase β-subunit isoforms (Figure 41). 
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Figure 41: TRAF2 E3 ubiquitin ligase ubiquitinates the intracellular domain of the Na,K-ATPase β-
subunit in vitro. TRAF2 immunoprecipitated from A549 cells was used to ubiquitinate cyt-β1 wt peptide in 
an in vitro ubiquitination reaction. As a negative control the cyt-β1 wt peptide was omitted. Biotinylated cyt-
β1 wt peptides were purified by streptavidin pull-downs and the Na,K-ATPase β-subunit ubiquitinated 
isoforms were detected with anti-ubiquitin antibody by IB. A representative Western blot is shown.  
 
These results suggest that TRAF2 has the capacity to ubiquitinate the Na,K-ATPase 
β-subunit. 
 
3.14. TRAF2 is required for hypercapnia-induced endocytosis of the Na,K-ATPase 
β-subunit 
 
Since our findings suggest that TRAF2 E3 ligase is able to interact with the Na,K-ATPase 
β-subunit and mediate its ubiquitination, we aimed to evaluate whether TRAF2 mediates 
hypercapnia-induced effects on Na,K-ATPase stability. For that, we evaluated the 
hypercapnia-induced endocytosis of Na,K-ATPase β-subunit in A549 cells in which 
TRAF2 was depleted by the use of specific siRNA against the protein. Results from these 
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experiments showed that TRAF2 depletion was sufficient to prevent the hypercapnia-
induced endocytosis of the Na,K-ATPase β-subunit (Figure 42). 
 
 
Figure 42: Knockdown of TRAF2 by siRNA prevents hypercapnia-induced endocytosis of the Na,K-
ATPase β-subunit. A549 cells were transfected with siRNA against TRAF2 or scramble siRNA. After 48 
hours transfection, cells were exposed to normocapnia (40 mmHg CO2, pH 7.4) or hypercapnia (110 mmHg 
CO2, pH 7.4) for 30 minutes. Biotin-streptavidin pull-down of cell surface proteins was performed and Na,K-
ATPase β-subunit abundance was analyzed by IB. Mean ± SEM, n = 3, paired t-test, *p<0.05. 
 
Altogether, these results provide evidence that TRAF2 acts as the E3 ligase for the 
Na,K-ATPase β-subunit, mediating the effects of hypercapnia on the protein. 
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4. Discussion 
 
Here we report a novel mechanism by which hypercapnia affects the function of the 
alveolar epithelium. We provide new evidence that elevated CO2 levels lead to the 
endocytosis and degradation of the Na,K-ATPase β-subunit which results in reduced 
ability of alveolar cells to form intercellular junctions. Our data show that ubiquitin chains 
covalently-attached to lysines 5 and 7 of the Na,K-ATPase β-subunit during hypercapnia 
are the primary signal leading to the endocytosis of the protein. Moreover, our results show 
that ubiquitination depends on PKC-ζ activity and involves the serine 11 residue of the 
Na,K-ATPase β-subunit. Most importantly, we identify TRAF2 as the E3 ligase that 
mediates the hypercapnia-induced ubiquitination of the Na,K-ATPase β-subunit. Our 
results are consistent with a key role of Na,K-ATPase β-subunit as a cell-adhesion 
molecule in the alveolar epithelium. 
 
4.1. Hypercapnia inhibits the formation of cell-cell contacts between alveolar 
epithelial cells by promoting endocytosis of the Na,K-ATPase β-subunit 
 
Hypercapnia is often observed in patients with ARDS and has been associated with worse 
patient prognosis [112, 117]. Several experimental studies support the existence of a causal 
link between hypercapnia and poor clinical outcomes [112, 127, 128, 203].  
Though the CO2 sensor remains unknown, it has been well-demonstrated that 
elevated CO2 is sensed by cells in the lung leading to deleterious effects on cell function, 
independently of intra- or extracellular pH. Indeed, elevated CO2 has been reported to 
activate AMPK, a master regulator of cellular adaptation to stressful conditions [128]. 
Under hypercapnic conditions, AMPK activation has been shown to promote PKC-ζ-
mediated phosphorylation of the Na,K-ATPase α-subunit and subsequent endocytosis of 
the protein, which results in impaired alveolar fluid clearance [127, 128]. 
Here we report that elevated CO2 levels impair the formation of new cellular 
junctions between alveolar epithelial cells. This CO2-associated adverse effect can 
particularly affect patients with ARDS, in which the alveolar epithelium is injured, and the 
organization of new cell contacts is required in order to re-establish the integrity of the 
alveolar epithelial barrier. 
We hypothesized that CO2-mediated down-regulation of one or more cell adhesion 
molecules may account for the CO2-associated inhibitory effects on cell adhesion. One 
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attractive candidate appeared to be the Na,K-ATPase β-subunit, which apart from its 
auxiliary role in the pump functionality, it is also a cell adhesion molecule that is involved 
in the organization and stability of cellular junctions [96]. The Na,K-ATPase β-subunit is 
normally located at the basolateral surface of epithelial cells where it mediates homophilic 
cell-cell adhesion [85, 86, 93]. Consistent with our hypothesis, the studies demonstrated 
that elevated CO2 levels lead to the endocytosis of the Na,K-ATPase β-subunit from the 
plasma membrane of alveolar epithelial cells. By biochemical studies in which we labeled 
plasma membrane proteins with impermeable biotin and by immunofluorescence 
microscopy, we were able to solidly demonstrate that elevated CO2 levels lead to a time-
dependent endocytosis of the Na,K-ATPase β-subunit, which is already evident after 6 
minutes of cell exposure to hypercapnia. 
Plasma membrane Na,K-ATPase β-subunit has a fundamental role in the 
organization and stability of tight and adherens junctions in epithelia [96]. In the light of 
our findings showing that elevated CO2 levels promote the ubiquitination-driven Na,K-
ATPase β-subunit endocytosis, we hypothesize that hypercapnia-associated impaired cell-
adhesion is a consequence of the reduced abundance of the Na,K-ATPase β-subunit protein 
at the plasma membrane of alveolar epithelial cells. To test the hypothesis, we conducted 
cell aggregation experiments in which we employed Na,K-ATPase β-subunit mutants 
containing lysine 5 and 7 replaced with arginines to prevent hypercapnia-induced Na,K-
ATPase β-subunit endocytosis. Results from these experiments show that Na,K-ATPase β-
subunit mutants which do not get ubiquitinated at lysines 5 and 7 are capable of restoring 
cell junctions formation in alveolar epithelial cells exposed to elevated CO2 levels. These 
findings solidly demonstrate that hypercapnia-triggered impaired cell-cell adhesion is 
mediated by the plasma membrane Na,K-ATPase β-subunit down-regulation. This is in 
agreement with our initial data in which we observed that MG-132, which prevents the 
endocytosis of the Na,K-ATPase β-subunit, also prevents the detrimental effects of 
hypercapnia on cell-cell contacts formation. 
 
4.2.  Ubiquitination of the Na,K-ATPase β-subunit acts as a signal for the 
endocytosis of the protein 
 
Ubiquitin is a key player in the regulation of the endocytosis of several membrane proteins 
[129, 197]. It has been proposed that ubiquitinated proteins are recognized by ubiquitin-
binding motifs present in various proteins that belong to the endocytic machinery, 
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coordinating protein internalization [197, 201]. Ubiquitination of the Na,K-ATPase β-
subunit during the normal turnover of the protein has been recently reported [193], but 
whether this process is required for the endocytosis or the degradation of the protein 
remained to be addressed. Interestingly, our studies demonstrated that elevated CO2 levels 
lead to rapid ubiquitination of the Na,K-ATPase β-subunit at the plasma membrane. To 
determine the ubiquitination site in Na,K-ATPase β-subunit, we conducted experiments in 
which all the intracellular lysines of the Na,K-ATPase β-subunit were substituted to 
arginines. Analysis of the data shows that only the simultaneous mutations of lysines 5 and 
7, prevents the hypercapnia-induced accumulation of the polyubiquitinated Na,K-ATPase 
β-subunit isoforms. This finding raises the question whether ubiquitin is attached randomly 
to one or the other lysine or whether there is a preferred lysine residue, but when mutated, 
the other lysine compensates the effect. Finally it is also possible that both lysines are 
ubiquitinated but one of them is enough to induce Na,K-ATPase β-subunit internalization. 
The flexibility in the ubiquitination site is not surprising, as the reactivity of a lysine seems 
to be enhanced by the presence of near-by basic residues proximal to the E3 ligase binding 
site [140, 153, 154]. The observation that the Na,K-ATPase β-subunit gets ubiquitinated at 
the plasma membrane is consistent with a role of ubiquitin chains in triggering 
hypercapnia-induced endocytosis of the protein. Indeed, internalization of Na,K-ATPase β-
subunit under hypercapnic conditions is prevented when lysines 5 and 7 of Na,K-ATPase 
β-subunit are replaced with arginines, demonstrating that the Na,K-ATPase β-subunit 
ubiquitination is absolutely required for the endocytosis of the protein. 
 
4.3. The activity of PKC-ζ is required for hypercapnia-induced ubiquitination of 
the Na,K-ATPase β-subunit 
 
Phosphorylation of a substrate may modulate its interaction with an E3 ubiquitin ligase. 
For some proteins, the phosphorylation sites are located close to the ubiquitination sites. 
Serine 11, present in the intracellular portion of the Na,K-ATPase β-subunit and proximal 
to lysines 5 and 7, was a potential phosphorylation site. When Na,K-ATPase β-subunit 
serine 11 is substituted for alanine (S11A) to prevent phosphorylation of the protein, 
hypercapnia-induced ubiquitination and degradation of the Na,K-ATPase β-subunit are 
prevented. The most likely explanation for this observation is that phosphorylation at 
serine 11 is required for the hypercapnia-induced ubiquitination of the Na,K-ATPase β-
subunit. However, the mutation of this amino acid could have other consequences than 
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preventing phosphorylation of the protein, such as simply disrupting an E3 ligase degron. 
To better understand the role of serine 11 in the ubiquitination of the Na,K-ATPase β-
subunit we conducted experiments in which we mimicked phosphorylation of the Na,K-
ATPase β-subunit by replacing its serine 11 with aspartate (S11D). In this case, the 
hypercapnia-induced ubiquitination and degradation of the Na,K-ATPase β-subunit are 
preserved, suggesting that serine 11 phosphorylation might be required for hypercapnia-
induced ubiquitination. There are multiple possibilities regarding the role of the 
phosphorylation of serine 11 of the Na,K-ATPase β-subunit in the ubiquitination of the 
protein. It may create a phosphodegron for the binding of an E3 ligase or it may induce 
conformational changes in the Na,K-ATPase β-subunit which may lead to the exposure of 
an existing E3 ligase degron. It has also been shown that the phosphorylation of the protein 
may lead to changes in the subcellular localization of the protein which may facilitate the 
interaction with an E3 ligase. However, the finding that Na,K-ATPase β-subunit gets 
ubiquitinated at the plasma membrane might argue against this possibility. One important 
observation is that the experiments do not show lower protein levels of the Na,K-ATPase 
β-subunit phosphomimic S11D than the Na,K-ATPase β-subunit wild type under basal 
conditions. This suggest that serine 11 is required but not sufficient to promote Na,K-
ATPase β-subunit ubiquitination-driven endocytosis and degradation. Therefore, we 
speculate that elevated CO2 levels may also regulate other players of the process of 
ubiquitination of the Na,K-ATPase β-subunit such as the E3 ligase activation. 
 One important issue that remained to be addressed was the identification of the 
kinase involved in the Na,K-ATPase β-subunit phosphorylation. Since elevated CO2 levels 
activates PKC-ζ, leading to its translocation to the plasma membrane where it 
phosphorylates the Na,K-ATPase α-subunit [127, 128], we hypothesized that PKC-ζ might 
also phosphorylate the Na,K-ATPase β-subunit under hypercapnic conditions. In line with 
our hypothesis, the results demonstrate that PKC-ζ interacts with the Na,K-ATPase β-
subunit. Since elevated CO2 levels lead to the recruitment of PKC-ζ at the plasma 
membrane of alveolar epithelial cells [128], it is not surprising that we observe that 
hypercapnia increases the interaction between both proteins. Furthermore, interaction 
assays in which we employed the intracellular domain of the Na,K-ATPase β-subunit with 
the intracellular serines mutated to aspartates show that only serine 11 mutation impairs 
Na,K-ATPase β-subunit interaction with PKC-ζ. Since enzymes generally display less 
affinity for their products [204], this result suggests that PKC-ζ mediates Na,K-ATPase β-
subunit serine 11 phosphorylation, thus confirming our previous studies. Importantly, 
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experiments in which PKC-ζ activity is inhibited or PKC-ζ cell expression is knocked 
down by the use of specific siRNA demonstrate that PKC-ζ is required for hypercapnia-
induced Na,K-ATPase β-subunit endocytosis. Interestingly, we have observed that PKC-ζ 
interacts with the Na,K-ATPase β-subunit at normal CO2 levels, which raises the question 
whether PKC-ζ may play a role in the basal turnover of the Na,K-ATPase β-subunit. 
However, the fact that PKC-ζ inhibition does not lead to an increase in plasma membrane 
Na,K-ATPase β-subunit protein abundance at basal levels does not support this speculation 
and further studies will be needed to understand this basal interaction between PKC-ζ and 
the Na,K-ATPase β-subunit.  
 The observed similarities in the regulation of the Na,K-ATPase α- and β-subunit 
localization at the plasma membrane under hypercapnic conditions, raise concerns about 
whether α- and β-subunit are regulated as a dimer or whether they are independently 
regulated. Although the Na,K-ATPase α- and β-subunit must be assembled as an 
heterodimer in order to be delivered to the basolateral membrane [68, 205, 206], once at 
the surface the Na,K-ATPase subunits have independent functions and its stability might 
be independently regulated [193]. We believe that our experimental data is consistent with 
a model in which hypercapnia directly regulates Na,K-ATPase β-subunit, independently of 
the Na,K-ATPase α-subunit. Indeed, our experiments have shown that PKC-ζ physically 
interacts with the cytosolic domain of the Na,K-ATPase β-subunit and this interaction is 
disrupted by the mutation of Na,K-ATPase β-subunit serine 11. Moreover our studies 
indicate that Na,K-ATPase β-subunit lysines 5 and 7, as well as the serine 11, are 
completely required for hypercapnia-induced ubiquitination-driven endocytosis and 
degradation of the protein. Altogether, these observations strongly suggest that Na,K-
ATPase β-subunit is directly regulated by elevated CO2 levels. Since PKC-ζ has also been 
shown to mediate CO2 effects on the Na,K-ATPase α-subunit promoting its endocytosis 
[128], we propose that hypercapnia-induced PKC-ζ activation leads to the PKC-ζ-mediated 
phosphorylation of each subunit which may trigger different regulation pathways, possibly 
implicating different molecular players.  
 
4.4. The proteasome activity is required for the degradation of the Na,K-ATPase β-
subunit under steady-state and hypercapnic conditions 
 
Consistent with the existence of distinct mechanisms of regulation for the plasma 
membrane Na,K-ATPase α- and β-subunit stability, one study done in HeLa cells has 
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shown that under steady-state conditions the half-life of the plasma membrane Na,K-
ATPase β-subunit in this cell-line is about ~4 hours whereas the half-life of the plasma 
membrane Na,K-ATPase α-subunit is about ~20 hours [193], thus demonstrating that the 
degradation of each subunit at the plasma membrane is independently regulated. In 
contrast, one study in A549 cells have shown similar half-lives for both Na,K-ATPase α- 
and β-subunit at the plasma membrane [194]. However, this finding does not necessarily 
imply a shared degradation pathway. 
 In addition to the distinct turnover rate of the plasma membrane Na,K-ATPase α- 
and β-subunit in some cell-lines, evidence suggest possible differences in the degradation 
pathway. Previous studies have shown that the Na,K-ATPase α-subunit turnover under 
steady-state or hypoxic conditions is lysosome-mediated [194]. In contrast, our studies on 
the Na,K-ATPase β-subunit turnover showed that treatment of A549 cells with 2 different 
widely-employed lysosome inhibitors, chloroquine and E-64, do not prevent plasma 
membrane Na,K-ATPase β-subunit endocytosis and degradation under steady-state or 
hypercapnic conditions. On the other hand, we have found that inhibition of the 
proteasomal activity in A549 cells with the proteasome inhibitor MG-132 prevents 
endocytosis and degradation of the Na,K-ATPase β-subunit. Similarly, studies in HeLA 
cells have shown that the plasma membrane Na,K-ATPase β-subunit degradation is 
prevented by proteasome inhibitors and its prevention leads to the accumulation of 
ubiquitinated Na,K-ATPase β-subunit isoforms [193]. However, one needs to be careful in 
the interpretation of these results. First, it is known that the proteasome inhibitors have an 
impact on the degradation of various intracellular proteins, which may directly or 
indirectly affect Na,K-ATPase β-subunit stability. For instance, endocytic machinery 
proteins, kinases and E3 ligases may be regulated by the proteasome [207-209]. Moreover, 
free ubiquitin molecules are normally recycled after protein degradation by the proteasome 
[210]. Therefore, proteasome inhibition may eventually lead to ubiquitin depletion which 
may affect ubiquitin-mediated endocytosis signaling and lysosomal degradation [211, 
212]. Nevertheless, without an evident effect of the lysosome inhibitors on the Na,K-
ATPase β-subunit stability, and in the light of the inhibitory effects of the proteasome 
inhibitors on the Na,K-ATPase β-subunit degradation, at the present we believe that it is 
likely that the proteasome is involved in the degradation of Na,K-ATPase β-subunit under 
both steady-state and hypercapnic conditions. We believe that future studies oriented to 
further confirm this hypothesis will be of interest, since the implication of the proteasomal 
pathway in the degradation of plasma membrane proteins, which is generally lysosome-
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mediated [213], is unusual. Nevertheless, recent evidence point to an interconnection 
between the degradation pathways and for example a proteasome pool associated with 
endosomes has been recently found to influence protein sorting [214].  
Although the exact pathway of degradation of the plasma membrane Na,K-ATPase 
β-subunit has still to be elucidated, we have gained some knowledge regarding the 
molecular pathway involved in the degradation of the intracellular Na,K-ATPase β-
subunit. Studies in which we employed a widely-used inhibitor of the protein synthesis, 
cycloheximide, allowed as to examine the turnover of the different Na,K-ATPase β-subunit 
isoforms. In line with studies from other groups [206], analysis of the data shows that 
under steady-state conditions the turnover of the core-glycosylated ER-associated Na,K-
ATPase β-subunit form is faster than the turnover of the fully-glycosylated form. 
Interestingly, the application of proteasome inhibitor in similar experiments, does not 
prevent the decrease in the core-glycosylated Na,K-ATPase β-subunit protein abundance, 
but leads to the accumulation of a lower molecular weight form of the Na,K-ATPase β-
subunit. Importantly, PNGaseF-treated deglycosylated Na,K-ATPase β-subunit protein 
comigrates in SDS-PAGE with this lower molecular weight form of Na,K-ATPase β-
subunit accumulated in the presence of the proteasome-inhibitor, suggesting that this form 
might be a deglycosylated intermediate of Na,K-ATPase β-subunit. In the light of this 
finding we hypothesize that the core-glycosylated ER-associated Na,K-ATPase β-subunit 
undergoes the already well-characterized ER-associated degradation pathway (ERAD), in 
which ER-localized glycoproteins are retrotranslocated, deglycosylated and proteasome-
degraded [196, 215, 216].  
 
4.5. TRAF2 E3 ligase mediates the ubiquitination of the Na,K-ATPase β-subunit in 
hypercapnia 
 
By specifically recognizing their substrates, the E3 ligases are the enzymes responsible for 
dictating the specificity of the ubiquitination process [160]. In order to identify the E3 
ligase involved in hypercapnia-induced ubiquitination of Na,K-ATPase β-subunit, we 
conducted a protein microarray in which we screened for proteins that interact with the 
Na,K-ATPase β-subunit. Since the binding of an E3 ligase to its substrate is a tightly 
regulated event [152], in order to preserve the interaction of the E3 ligase with the Na,K-
ATPase β-subunit we compensated the absence of regulation of the protein by CO2 with an 
alternative approach. Based on our previous results which suggest that hypercapnia-
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mediated phosphorylation of the Na,K-ATPase β-subunit serine 11 might be required for 
its ubiquitination, we used the Na,K-ATPase β-subunit phosphomimic (S11D) as a bait in 
the screening. After a thoughtful analysis of the information available in the literature 
about all the E3 ligases which were found to interact with the Na,K-ATPase β-subunit, we 
identified TRAF2 as a likely candidate. TRAF2 is a RING E3 ligase [198], well-known by 
its role in the activation of the NF-κβ signaling pathway [217]. TRAF2 catalytic activity 
has been shown to be promoted by the binding of sphingosine-1-phosphate (S1P), 
intracellularly produced by sphingosine kinase 1 (Sphk1) [198]. Three reasons led us to 
consider TRAF2 as a potential E3 ligase for the Na,K-ATPase β-subunit. First, we found a 
major TRAF2 binding motif (P/S/T/A)X(Q/E)E [218] in the Na,K-ATPase β-subunit 
intracellular domain, which comprises the lysine 7 and is in close proximity to lysine 5 and 
serine 11 of the Na,K-ATPase β-subunit (Figure 43). Second, sphingosine kinase 2 
(Sphk2) was also found to significantly interact with Na,K-ATPase β-subunit in the protein 
microarray, and we speculated that S1P production by Sphk2, in proximity to Na,K-
ATPase β-subunit may serve as the cofactor required for TRAF2 ubiquitin ligase activity. 
Third, TRAF2 mediates K63-linked polyubiquitination. [198] which has been shown to 
regulate the endocytosis and protein sorting of some plasma membrane proteins [168, 173] 
and could therefore regulate the ubiquitination-driven endocytosis of the Na,K-ATPase β-
subunit under hypercapnic conditions. 
 
       
 
Figure 43: The amino acid sequence of the intracellular domain of the Na,K-ATPase β-subunit. The 
scheme shows the lysines 5 and 7 of the Na,K-ATPase β-subunit which get ubiquitinated under hypercapnic 
conditions. It shows the serine 11 of the Na,K-ATPase β-subunit which is required for hypercapnia-induced 
ubiquitination of the protein. Moreover, it shows TRAF2 binding motif present in Na,K-ATPase β-subunit 
which comprises the lysine 7 of the Na,K-ATPase β-subunit. 
 
We conducted coimmunoprecipitation studies which we confirmed that TRAF2 
interacts with the Na,K-ATPase β-subunit. Moreover, we demonstrated that the 
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overexpression of TRAF2 in A549 cells promotes the accumulation of the ubiquitinated 
Na,K-ATPase β-subunit isoforms. Most importantly, by in vitro studies we demonstrated 
that TRAF2 directly interacts and ubiquitinates the intracellular domain of the Na,K-
ATPase β-subunit. These findings provide compelling evidence that TRAF2 is an E3 ligase 
of the Na,K-ATPase β-subunit. Whether TRAF2 E3 ligase activity is required for 
hypercapnia-induced Na,K-ATPase β-subunit endocytosis was evaluated by the cell 
knockdown of TRAF2 protein with the use of specific siRNA. This experiments solidly 
demonstrated that TRAF2 is absolutely required for hypercapnia-mediated ubiquitination-
driven endocytosis of the Na,K-ATPase β-subunit.  
Ubc13/Uev1A is an E2 ubiquitin conjugating enzyme complex which has been 
reported to interact with TRAF2 and mediate K63-linked ubiquitination of target proteins 
[219]. The fact that the in vitro ubiquitination of the Na,K-ATPase β-subunit was 
conducted in the presence of the Ubc13/Uev1 E2 complex suggests the possibility that 
Na,K-ATPase β-subunit gets ubiquitinated through K63-linked chains. Since K63-linked 
ubiquitination has been implicated in the regulation of protein transport [168, 173], K63-
linked polyubiquitination of Na,K-ATPase β-subunit could account for the role of 
ubiquitination in promoting the endocytosis of the protein. Future studies oriented to 
elucidate the topology of Na,K-ATPase β-subunit ubiquitin chains will provide a better 
understanding of the CO2-regulated  Na,K-ATPase β-subunit endocytosis. 
The experiments in which TRAF2 protein was depleted from cells did not show an 
increase in total plasma membrane abundance of Na,K-ATPase β-subunit protein. One 
possible explanation for this observation is that TRAF2 may not be involved in the 
turnover of the Na,K-ATPase β-subunit under steady-state conditions. Though required in 
hypercapnia-induced Na,K-ATPase β-subunit ubiquitination, TRAF2 may not be the only 
E3 ligase involved in the regulation of surface expression of the Na,K-ATPase β-subunit. 
Moreover, ubiquitination might not be the only mechanism involved in the endocytosis of 
the protein. Other mechanisms may account for Na,K-ATPase β-subunit endocytosis under 
normal or other stressed-associated conditions.  
Considering the role of ubiquitination in the protein degradation pathways, it still 
remains to be elucidated whether hypercapnia-induced β-subunit degradation requires 
other ubiquitination events. Based on our studies suggesting a possible role of the 
proteasome in mediating hypercapnia-induced Na,K-ATPase β-subunit degradation we 
speculate that there might be other hypercapnia-induced Na,K-ATPase β-subunit 
ubiquitination steps possibly involving K48-linked polyubiquitination of the protein.  
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Future studies will be required to gain understanding in the mechanism(s) 
underlying the hypercapnia-induced TRAF2 activation. We believe that Sphk2, which has 
been found to interact with the Na,K-ATPase β-subunit in the protein microarray, may 
participate in the activation of TRAF2. Sphk2 expression, which is tightly regulated in 
alveolar epithelial cells, has been reported to be upregulated by ERK under hypoxic 
conditions [220]. Most importantly, since ERK has also been shown to be activated by 
hypercapnia [221] we propose a plausible mechanism in which hypercapnia-induced ERK-
mediated Sphk2 activation, leads to S1P production in the proximity of the Na,K-ATPase 
β-subunit which activates TRAF2 E3 ligase that mediates the ubiquitination of the Na,K-
ATPase β-subunit at the plasma membrane.  
 
4.6. Concluding remarks 
 
Previous studies have demonstrated that hypercapnia causes detrimental effects on the 
function of the alveolar epithelial cells such as mitochondrial dysfunction and impaired cell 
proliferation [203]. CO2 levels have also been found to promote the endocytosis of the 
Na,K-ATPase α-subunit which leads to impaired alveolar fluid reabsorption in the lung 
[127, 128]. In the present studies we provide evidence of a new mechanism by which 
hypercapnia has adverse effects on the alveolar epithelium. By down-regulating the 
expression of the plasma membrane Na,K-ATPase β-subunit, hypercapnia impairs the 
ability of alveolar cells to interact with each other. Since new cell junctions formation is 
essential for the process of repairing the alveolar epithelium after ARDS, elevated CO2 
levels in the alveolar epithelium of patients with ARDS may lead to persistent dysfunction 
of the alveolar epithelium, which is associated with worse patient prognosis [9, 15, 16, 29, 
33, 34]. Considering that Na,K-ATPase β-subunit endocytosis alone is enough to impair 
the formation of adherens junctions, our findings highlight the key role of the protein in 
alveolar epithelium as an adhesion molecule.  
In the present work, we elucidate the molecular mechanism involved in 
hypercapnia-mediated Na,K-ATPase β-subunit down-regulation (Figure 44). We 
demonstrate that elevated CO2 leads to PKC-ζ-mediated regulation of Na,K-ATPase β-
subunit, which triggers TRAF2-mediated ubiquitination of the protein, which results in the 
endocytosis and degradation of Na,K-ATPase β-subunit. The decision to orient our 
research toward the identification of the hypercapnia-associated E3 ligase of the Na,K-
ATPase β-subunit was based on the notion that E3 ubiquitin ligases determine the 
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specificity of the ubiquitination process by targeting the specific substrates. Considering 
the relevant role of Na,K-ATPase β-subunit in cell adherens junction formation in alveolar 
epithelial cells, the identification of the E3 ligase of the Na,K-ATPase β-subunit provides 
with a potential therapeutic tool to be employed not only in ARDS but also in other lung 
diseases in which cell adhesion events are involved, such as lung cancer and fibrosis. 
 
 
 
Figure 44: Model for hypercapnia-mediated inhibition of cell-cell contacts (See section 4.6. for detailed 
explanation). 
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